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Abstract
Farimah, Salami, Ph.D. The University of Memphis. August 2015. Molecular
Role of Dab2ip GTPase Activating Protein in Brain Development. Major Professor: Dr.
Ramin Homayouni.
Dab2ip is a member of Ras GTPase activating protein family that interacts with
Disabled-1/2 family proteins, which play a critical role in brain development. Dab2ip is
mainly known as a tumor suppressor, however recent studies have shown that it has
important functions in the mammalian brain.
In this study, using bioinformatics and experimental techniques, I characterized
the mouse Dab2ip gene structure. Unlike previous reports, I found that the mouse Dab2ip
gene has 20 exons and 3 CpG islands. I identified three transcript variants of Dab2ip
which start from exon one. Alternative splicing at the 5' end of these transcripts results in
the presence or absence of exons 3 and 5. Interestingly, these two exons contain CpG
islands 54 and 85, suggesting that methylation may control inclusion of these exons in the
transcript. Quantitative RT-PCR and methylation experiments revealed that CpG 85
methylation increases during cerebellar development and positively correlates with the
inclusion of exon 5 in the Dab2ip transcript. Importantly, inclusion of exon 5 results in
the expression of a full length PH domain in Dab2ip protein.
In the second part of my studies, I examined the effect of the PH domain on
Dab2ip GAP activity toward Ras and Rap1. I found that the presence of full length or the
C-terminal half of the PH domain results in specificity of Dab2ip toward Rap1 but not
Ras. Live cell imaging showed that the Dab2ip PH domain allows it to activate Rap1
GTPase activity at both the plasma membrane and cytosolic structures. Thus, my results
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suggest that the presence of the PH domain may regulate Rap1 specificity, possibly by
allowing Dab2ip to interact with membrane structures that are Rap1 enriched.
Precise activation and inactivation of Rap1 signaling is critical for neuronal
development. The increased DNA methylation and expression of Dab2ip transcript
variant correspond to the period in cerebellar development when neurons are forming
synapses. My results suggest that Rap1 signaling inactivation by Dab2ip plays an
important role during this period of cerebellar development. Indeed, my results are
consistent with our previous observation that Dab2ip deficient animals have lower
granule cell synapses.
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Chapter 1. Introduction

1.1 Reelin pathway in brain
One of the critical steps in the brain development and formation of distinct brain
regions is neuronal positioning which occurs through a series of the coordinated
migrations which takes neurons from their site of origin to their final destinations. After
migration finished neurons start their morphological changes by elaborating dendritic and
axonal process (Ram´on y Cajal, 1955).
A new signaling pathway that involves in neuronal cell positioning is Reelin
signaling pathway. Reelin is a large extracellular protein that is produces by specific
population of the cells in the brain. After secretion, Reelin binds to the transmembrane
receptors, the very low-density lipoprotein receptor (VLDLR) and apolipoprotein E
receptor 2 (ApoER2) present on migrating neurons (D’Arcangelo et al., 1999; Hiesberger
et al., 1999). Disable-1 (Dab1) is an intracellular adapter protein which interacts with
cytoplasmic domains of these receptors (Trommsdorff et al., 1999). Binding of Reelin to
lipoprotein receptors induces tyrosine phosphorylation of Dab1 which triggers an
intracellular signaling cascade that conducts neurons to become bipolar and migrate to
their proper location in the developing central nervous system (CNS). Morphological
changes of the neuron during migration from multipolar to bipolar and from bipolar to
multipolar again and also dendrite and axon formation after positioning is the result of the
cytoskeletal changes which occur through small GTPases such as Ras and Rap1 (Yang
and Terman, 2013). Disruption of the Reelin gene in reeler mice causes massive
neuronal positioning defects in their brain, which occurs at early ages of the brain
development (Desilva et al., 1997).
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1.2 Overview of Dab2ip
Dab2ip is a novel member of Ras GTPase-activating protein (GAP) family which
has been identified in several mammalian species (Homayouni et al., 2003a; Wang et al.,
2002b; Zhang et al., 2003b). The first Dab2ip isoform, Rat DIP1/2 was identified in 2002
(Wang et al., 2002b). DIP 1/2 is able to interact with DOC-2/DAB2, a potential tumor
suppressor, and its overexpression inhibits the growth of C4-2 cells, a tumorigenic human
prostate cancer cell line (Wang et al., 2002b). A partial mouse homolog of Dab2ip was
first isolated as a Disable-1(Dab1)-interacting protein in the brain, and this interaction
was confirmed in vivo (Homayouni et al., 2003a). Dab1, by regulating neuronal
migration and dendrite development, has a critical role in Reelin signaling pathway (Niu
et al., 2004; Rice and Curran, 2001).
The human homolog of Dab2ip was isolated via its interaction with the apoptosis
signal regulating kinase 1 (ASK1)-interacting protein (AIP1) (Zhang et al., 2003b).
ASK1 is an upstream activator of JNK and P38 mitogen-activated protein kinase
(MAPKs) (Davis, 2000). Using embryonic fibroblasts from AIP1 knock-out mice, it was
shown that AIP is critical for transducing endoplasmic reticulum stress response (Luo et
al., 2008). Interestingly, it was also shown that AIP1 exists in a folded form by forming
an intramolecular interaction, which is regulated byTNF-α (Zhang et al., 2003b). After
unfolding, AIP1 is able to increase TNF-α induced ASK1 activity that leads to activation
of JNK (Zhang et al., 2003b).
Dab2ip contains several small protein domains and distinct regions, which appear
to be involved in its biological function: Plekstrin homology domain (PH), PKC
conserved 2 (C2) domain, GAP-related domain (GRD), NpXY motif and proline-rich
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region (Fig. 1A). The GRD domain, which is the catalytic domain of Dab2ip, is found in
all Dab2ip transcripts identified to date.
To date different Dab2ip cDNAs have been isolated and reported to GenBank
database. In human, at least three different variants are detected: Acc# NP_115941 (1132
aa), Acc# AY032952 (1065 aa) and Acc# NP_BC146762 (1036 aa). Since the initial
report of mouse Dab2ip cDNA (Chen et al., 2006), several more mDab2ip cDNAs have
been isolated and reported to GenBank database: Acc# AK147464 (1189 aa), Acc#
DQ473307 (1132 aa), Acc# AK147593 (1065 aa) (Fig. 1B). Most of the differences
among Dab2ip transcript variants are at the 5′ and 3′ ends corresponding to the Nterminal and C-terminal regions of the final proteins. Additional exons at the 5′ end in
some of the transcript variants encode a longer N-terminal PH domain whereas variation
of exons in the 3′ end leads to the presence or absence of an SMH, Serine-MethionineHistidine, PDZ interaction domain in the protein.
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A

human Dab2ip (NP_115941)
human AIP1/Dab2ip (AY032952)
human Dab2ip (NP_BC146762)
mouse Dab2ip-L (DQ473307)
mouse Dab2ip (AAI18531)
mouse Dab2ip (AY305656)
rat DIP1/2 (AF236130)

B

Figure 1. Schematic representations of mammalian Dab2ip protein isoforms. (A)
Currently, six different isoforms of Dab2ip protein can be deduced from cDNAs reported
in Genebank. The highest variability is at the C-terminus and N-terminus of the proteins.
(B) Protein domain structure of longestDab2ip isoform contains a Pleckstrin homology
(PH) domain (residues 59-170), a C2 domain (residues 177-265), a GAP related domain
(GRD) (residues 308-632), an NPXY motif (residues 802-805) and a Proline-rich region
(residues 892-910).
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1.2.1 Dab2ip in the brain
In addition to its roles in tumor formation and apoptosis in other systems, Dab2ip is also
highly expressed in the brain where it interacts with Dab1, a key mediator of the Reelin
pathway that controls several aspects of brain development and function (Homayouni et
al., 2003). The wide expression profile of Dab2ip protein through the brain including
olfactory bulb, hypothalamus, cerebellum and cerebellar cortex in different ages verifies
its critical role during brain development (Qiao et al., 2013).
Recent studies showed that Dab2ip is important for proper positioning of a subset
of layer II-IV neurons in the developing cortex (Qiao, 2015). Down regulation or
overexpression of Dab2ip severely disrupts neuronal migration (Lee et al., 2012). In the
cerebellum, Dab2ip is expressing in various cerebellar neurons and is distributed in the
cell bodies in the molecular layer and granule cell layer. Also, some expression of Dab2ip
has been seen in the soma and dendrites of the Purkinje cells. KD mice studies indicate
that Dab2ip is required for early stages of PC dendrite development (Qiao, 2013).
Although the molecular mechanism for the involvement of Dab2ip in early development
of the Purkinje cells is not completely understood, some recent studies have shown that
the role of Dab2ip in PC dendrite development is through cytoskeletal changes which are
due to Dab2ip’s effect on Rap1 and integrin activity (Qiao, 2015).
Previously it has been shown that Ras and Rap1 play important roles in axon
elongation, branching and synapse formation. And also others have shown that Rap1
regulates the transition between multipolar to bipolar morphology in migrating postmitotic neurons through N-cadherin signaling and somal translocation in the superficial
layer of the cortical plate through integrin signaling (Fransco et al., 2011; Selkine et al.,
2012; Jossin et al., 2011). Dab2ip KD mice showed higher activation of the integrin and
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Rap1that verifies Dab2ip does its role in cerebellar development through integrin and
Rap1 (Qiao, 2015).
1.3

Overview of epigenetics and genome regulation
Although effectively all cells in an organism contain the same genetic

information, not all genes are expressed simultaneously by all cell types. Also, not all
characteristics of living organisms can be explained by their genes. In fact, some factors
other than the primary DNA sequence are important cellular and physiological functions.
Epigenetics, literally defined as heritable changes, affects cell characteristics over time
(Stupar et al., 2013). In contrast with genetics, (i.e., the study of direct alteration of the
DNA sequence such as point mutation, deletion, insertions and translocation), epigenetics
is the study of changes in gene activity or function that is not associated with any change
in the DNA sequence itself. In fact, epigenetic mechanisms are responsible for different
gene expression profiles in a variety of cells and tissues in multicellular organisms and
mediate stable alterations in gene expression during development and cell proliferation.
Although epigenetics is essential for development and differentiation, it can also play a
role in mature organisms, either by random changes or as a result of environmental
influences (Toyota and Issa, 1999).
The best studied epigenetic modification is methylation of DNA on cytosine
bases. Generally, cytosine methylation causes gene silencing, through inhibition of
transcription machinery. In mammals, DNA methylation primarily occurs on the fifth
carbon of the cytosine base, forming 5-methylcytosine or 5-methylcytidine (5-mC)
(Compere and Palmiter, 1981; Holliday and Pugh, 1975). 5-methylcytosine (5mC) is
widespread throughout the mammalian genome and found on as many as 80% of CpG
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dinucleotides (Rose and Klose, 2014). Methylated CpG clusters at gene promoters, or
CpG islands, have been associated with gene inactivation which prevents transcription
via several mechanisms, including inhibition of transcription factor binding (Deaton and
Bird, 2011).
Histone modification also plays an important role in epigenetic regulation.
Histones are highly basic proteins that pack DNA into chromatin structures in order to fit
into a much smaller nucleus. Histones possess long N-terminal tails composed mainly of
basic-amino acids residues (histidine, lysine and arginin). Post translational epigenetic
modification of the basic side-chains in histone tails can be in the forms of methylation,
acetylation, phosphorylation and ubiquitinylation (Garske et al., 2008; Turner, 2005).
DNA modification typically corresponds to long-term epigenetic memory: once
methylated, genomic DNA may remain methylated through generations. Histone
modifications, on the other hand, typically provide short-term epigenetic memory and can
be lost after a few cell division cycles. DNA methylation, plays an important role in
many biological processes. For example, in prokaryotes, it is involved in virulence, cell
cycle regulation, gene expression and protection from foreign DNA introduction (DNAhost specificity) (Ratel et al., 2006). In higher eukaryotes, DNA methylation is involved
in the regulation of several cellular processes such as chromatin stability, imprinting, X
chromosome inactivation and carcinogenesis (Kar et al., 2012).
1.3.1

Mechanism of DNA methylation
Replication of methylated DNA leads to hemimethylated DNA in which the

parent strand is methylated while the daughter strand has not methylated yet. Methylation
of this hemimethylated DNA is necessary to complete the replication of methylated DNA
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(Crider et al., 2012). DNA methylation is catalyzed by a family of enzymes called DNA
methyltransferase (DNMTs). At least three independent DNMTs are involved in DNA
methylation and fall into two categories: de novo methyltransferases (DNMT3A and
DNMT3B) methylate unmethylated DNA, whereas maintenance methyltransferases
(DNMT1) methylate hemimethylated DNA (Robertson et al., 1999). The maintenance
methylation of hemimethylated DNA provides a mechanism for inheritance of a
methylation pattern through generation, making DNA methylation a stable epigenetic
modification.
The general mechanism of methylation of cytosine involves electrophilic attack
by the cofactor S-adenosyl-I-methionine (Adomet; SAM), which transfer a methyl group
to C(5) of cytosine, and is converted to S-adenosyl-I-homocysteine (AdoHcy; SAH) in
the process (Fig. 2). As the C(5) atom of cytosine is not particularly nucleophilic, some
help is needed from the methyltransferase to activate it and increase its nucleophilicity.
DNA methytransferases contain a conserved cytosine residue, which upon deprotonation
to the thiolate anion, acts as a strong nucleophile. The cysteine thiolate attack the C(6)
atom of cytosine in a conjugate addition reaction, and a covalent bond is formed between
the cysteine sulfur atom and the cytosine C(6) atom. The negative charge on cytosine is
stabilized by interaction with a glutamate residue. Nucleophilic attack then takes place on
the methyl group of S-adenosyl-I-methionine, which is converted to S-adenosyl-Ihomocysteine (AdoHcy). Finally β-elimination occurs across the C(5)-C(6) bond,
releasing the enzyme. In the mechanism of methyltransferase-catalyzed methylation of
cytosine, a base is required to deprotonate the cysteine to form the (more nucleophilic)
thiolate. It is proposed that the base involved in this reaction is a DNA phosphate group,
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Figure 2. Schematic of the methylation reaction catalyzed by DNMT. In the first step,
a nucleophile from the enzyme (Cys81) attacks position 6 of cytosine. This activates
position 5 for an electrophilic attack by the cofactor, AdoMet, where a methyl group is
transferred to cytosine. Subsequent elimination of the enzyme nucleophile and
abstraction of the proton at position 5 yield the methylated cytosine and the enzyme
(Zangi et al., 2010).
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via a bridging water molecule. Therefore, DNA acts as both a substrate and a cofactor
(Fig. 2) (Zangi et al., 2010).
1.3.2

Mechanisms of gene regulation by DNA methylation
There are several ways by which DNA methylation can repress transcription. One

way is through the exclusion of proteins that affect transcription by interfering with their
DNA binding sites (Watt and Molloy, 1988). One example of this protein exclusion is
CTCF which blocks the interaction between an enhancer and its promoter when
positioned between the two elements (Bell et al., 1999; Ohlsson et al., 2001). CpG
methylation blocks the binding of CTCF to DNA and thus allows an enhancer to
stimulate promoter activity across the inert boundary site. This occurs in Igf2 gene,
which is expressed exclusively from parental allele during development (Hark et al.,
2000; Ohlsson et al., 2001; Szabo et al., 2004). In addition to binding of CTCF to the
DNA, some transcription factors are directly blocked by CpG methylation (Tate and Bird,
1993). Although DNA methylation clearly inhibits DNA binding of some proteins such
as transcription factors, it can also attract other DNA binding proteins. For example,
MeCP2 and its relatives such as CpG binding domain proteins MBD1-MBD4 (Hendrich
and Bird, 1998; Lewis et al., 1992) as well as unrelated protein Kaiso (Prokhortchouk et
al., 2001) contain methylated CpG binding domains (Hendrich and Bird, 1998; Nan et
al., 1993). Methyl CpG binding proteins such as MeCP2, MBD2 and MBD1 function as
transcriptional repressors because in their absence methylated reporter genes are
expressed (Boyes and Bird, 1991).
To date, many correlations between an increase in expression and loss of DNA
methylation have been reported. In some studies it has been shown that inactivation of
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DNMT1 leads to activation of genes during development. The first evidence for the
induction of premature gene activation by demethylation was reported for the frog
Xenopus laevis (Stancheva and Median, 2000; Stancheva et al., 2001). Widespread gene
expression normally occurs at the mid-blastula transition and is correlated in time with
promoter demethylation. Similarly, widespread activation of tissue-specific genes has
been seen in fibroblasts after conditional inactivation of DNMT1 (Jackson-Grusby et al.,
2001). Therefore gene activation in the frog is delayed until the mid-blastula stage
through DNA methylation.
1.4

Overview of mRNA splicing
Alternative splicing of mRNA allows for a single gene to encode multiple

proteins, with different molecular functions. In human, about 95% of multi-exonic genes
are alternatively spliced (Pan et al., 2008) and more than one third of the human genome
have at least two variants of exon-intron structures (Mironov, 1999). There are several
types of common gene splicing events: 1) Exon skipping or cassette exon is the most
common known gene splicing mechanism in which exons are included or excluded from
the final gene transcript leading to extended or shortened mRNA variants. 2) Mutually
exclusive exons which caused only one of two exons to be retained in mRNA after
splicing. 3) Intron retention is an event in which an intron is retained in the final
transcript. In human 2-5 % of the genes have been reported to retain introns (Clark and
Thanaraj, 2002; Kan et al., 2002). 4) Alternative 3′ splice site and 5′ splice site, which
includes joining of different 5′ and 3′ splice site (Ghigna et al., 2008). This mechanism
results in two or more alternative 5′ splice sites to compete for joining to two or more
alternate 3′ splice sites.
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1.4.1

The splicing machinery
The excision of the introns from a pre-mRNA and the joining of the exons are

directed by special sequences at the intron/exon junctions called splice sites. The 5′ splice
site marks the exon/intron junction at the 5′ end of the intron. This includes a GU
dinucleotide at the 5’ end of an intron surrounded by a larger, less conserved consensus
sequence. The 3′ splice site of an intron has three conserved sequence elements: the
branch point, followed by a polypirimidine tract, followed by a terminal AG at the
extreme 3′ end of the intron (Burge et al., 1999; Will and Lührmann, 2011). Splicing is
carried out by the splicesome, which is composed of five small nuclear
rebonucleoproteins (snRNPs U1, U2, U4, U5, and U6) and more than 100 different
polypeptides (Burge et al., 1999; Ghigna et al., 2008; Nilsen, 2002; Staley and Guthrie,
1998). The spliseosome recognizes splice sites and then assembles onto these sequences.
During the assembly, the early complex (E) contains U1 snRNP bound to the 5′ splice
site. This occurs through direct base pairing between early complex and 5′ splice site. The
3′ splice site elements are bound by a special set of the proteins. SF1 is a branch-point
binding protein. The 65-kDa subunit of the dimeric U2 auxiliary factor (U2AF) binds to
the polypyrimidine tract. In at least some cases, the 35-kDa subunit of U2AF binds to the
AG at the intron/exon junction. The E complex (or commitment complex) which contains
U1 and U2AF bound at the two intron ends and joined by U2 snRNP to form A complex.
The A complex is joined by the U4/U5/U6 tri-snRNP to form the B complex. The B
complex undergoes a complicated rearrangement to form the C complex, in which the U1
snRNP interaction at the 5′ splice site is replaced with U6 snRNP and the U1 and U4
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snRNP are lost from the complex. It is the C complex that catalyzes the two chemical
steps of splicing (Burge et al., 1999; Staley and Guthrie, 1998).
The splice site consensus sequences are generally not sufficient to determine
whether a site will assemble a splicesome and function in splicing. Other information and
interactions are necessary to activate their use (Black, 1995; Berget 1995). RNA elements
that act positively to stimulate splicesome assembly are called splicing enhancers. There
are also some intronic enhancers of splicing. Conversely, other RNA sequences act as
splicing silencers or repressors to block splicesome assembly and certain splicing choices
(Black, 1995). On the other hand, Cis-regulatory elements can serve as either splicing
enhancers or silencers. These elements are conventionally classified as exonic splicing
enhancers (ESEs) or silencers (ESSs) if from an exonic location. They function to
promote or inhibit inclusion of the exon in which they reside. On the other hand intronic
splicing enhancers (ISEs) or silencers (ISSs) can enhance or inhibit usage of adjacent
splice sites or exons from an intronic location. In general, these splicing regulatory
elements (SREs) function by recruiting trans-acting splicing factors that activate or
suppress splice site recognition or spliceosome assembly by various mechanisms (Chasin,
2007; Matlin et al., 2005). ESEs function by recruiting members of the SR protein family
(Graveley, 2000). SR proteins usually regulate splicing by binding ESEs through their Nterminal domains and mediating protein-protein interactions that facilitate splisosome
assembly through C-terminal domains (Graveley and Maniatis, 1998).
1.5

Role of epigenetics and chromatin structure in alternative splicing
The first evidence that chromatin structure participates in the regulation of

alternative splicing was the finding that fibronectin exon E33 inclusion was sensitive to
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replication-mediated chromatinization status of the plasmid and to the histone deacetylase
inhibitor TSA (Kadener et al., 2001; Nogués et al., 2002). Further support came from the
study of hormone-sensitive promoters that were tested for their effects on alternative
splicing of a CD44 reporter gene (Auboeuf et al., 2002). Recently, some advanced
methods have mapped chromatin structure at a genome-wide scale which further supports
a role for chromatin structure in alternative splicing. Using these methods, it was found
that nucleosomes are positioned non-randomly along genes and are particularly enriched
at intron-exon junctions, thus making final exons (Andersson et al., 2009; Chodavarapu
et al., 2010). A nucleosome encompasses a stretch of ~147 bp of DNA, wrapped around
an octamer of histone proteins. Interestingly, the average size of a mammalian exon is
similar to the length of DNA wrapped around a nucleosome, possibly pointing to a
protective role of the nucleosome and a function in exon definition (Schwartz et al., 2009;
Tilgner et al., 2009). In fact, analysis of nucleosome enrichment, which mostly occurs
around exons, suggests an essential role of nucleosome positioning in defining an exon
and is conserved in evolution from plants to mammals in both somatic and gametes
(Nahkuri et al., 2009). Furthermore, isolated exons in the middle of long introns carries
higher nucleosome positioning than clustered exons separated by small introns (Spies et
al., 2009). Moreover, pseudo-exons, which are non-included intronic sequences flanked
by strong splice sites, are depleted of nucleosomes and mostly nucleosomes are
positioning by weaker splice site exons (Tilgner et al., 2009). All together, these recent
data argue for a role of nucleosome positioning not only in exon definition but also in the
regulation of splicing. The density of the RNA Pol II, the strength of the promoter or
saturation of the splicing machinery can be other factors that effect on splicing.
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1.5.1

Possible mechanisms of epigenetic control of Splicing
It has been suggested that the rate of RNA synthesis affects its secondary

structure, which in turn affects splicing (Eperon et al., 1988). Further evidence for a
kinetic link between transcription and splicing came from experiment in which a MAZ
sequence, which results in RNA pol II pausing, inserted into the tropomysin gene
promoted higher inclusion of tropomysin exon 3 (Roberts et al., 1998). Finally, a slow
mutant of RNA Pol II increased exon 33 inclusion in human cells. This effect was
counteracted by treating the cells with TSA (trichostatin A) which is a histone
deacetylation inhibitor (Cramer et al., 1997; De La Mata et al., 2003; Kornblihtt, 2005).
There are some agreements among scientists that the presence of weak and strong
splicing sites in the genome can influence alternative splicing (Kadener et al., 2001). This
scenario hypothesizes that rapid elongation of RNA Pol II results in simultaneous
availability of a weak and a strong splice site to the splicing machinery. The competition
between the two sites for the splicing machinery leads to skipping of the weaker exons.
On the other hand, it is possible that RNA Pol II pausing results in the recruitment of the
splicing machinery to the first transcribed splicing junction, which would result in the
weaker exons to be included in the final mRNA. Therefore the distance between the
competing splice sites appears to be important for epigenetic regulation of weak exons.
Another mechanism by which epigenetics could regulate splicing is through
histone modification. Although there is no any experimental evidence yet, it is possible
that DNA methylation directly or indirectly through histone modifications affect splice
site choice. Mapping of DNA methylation in plant and human cells by single molecule
whole genome bisulfate sequencing revealed that DNA methylation is also nonrandomly
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distributed along the genome specially marking exons (Chodavarapu et al., 2010) and
correlated with H3K36me3 but inversely correlated with H3K9me2 levels (Hodges et al.,
2009). These observations suggest a role for epigenetic modifications in the modulation
of RNA polymerase II elongation rate which affect regulation of alternative splicing.
1.6

Overview of Ras subfamily and their regulators (GAPs and GEFs)

1.6.1 The Ras Subfamily
P21 Ras was first identified as a proto oncogene having 21 KDa molecular weight
in 1960’s oncogentic virus studies (Anderson et al., 1992; Kirsten and Mayer, 1967). In
these studies, the proteins encoded by viral genes responsible for the tumorogenesis were
found to be a mutated version of small GTPase Ras. The Ras superfamily now includes
over 150 small GTPases categorized in six subfamilies: the Ras, Rho, Ran, Rab, Arf and
Kir/Rem/Rad subfamilies. The Ras subfamily has at least 13 members that fall into 5
subgroups, including Ras (H-Ras, N-Ras, K-Ras4A, and K-Ras4B), Rap (Rap1A, Rap1B,
Rap2A, and Rap2B), R-Ras subgroup (R-Ras, R-Ras2 and M-Ras), Ral subgroup (RalA
and RalB), and Reb subgroup (Rheb). All four Ras isoforms are identical to each other in
the N-terminal sequence whereas at the C-terminus, they differ substantially. The last 1020 amino acids of Ras are considered to be the hyper variable region (Onken et al., 2006;
Chang and Philips, 2006). In all Ras subgroups individual members share at least about
40% of sequence identity, and about 85 % of sequence similarity is shown within one
subgroup (Colicelli, 2004; Ehrhardt et al., 2002). In addition, several new Ras-like
GTPases have been identified. However some characteristic features of Ras proteins like
prenylation signals and typical effector domains don’t exist in these molecules (Reuther
and Der, 2000).
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1.6.2

Regulation of small GTPases
Small GTPases (G-proteins) are able to switch between an inactive and an active

form, via hydrolysis of GTP. GDP-bound state is inactive whereas GTP-bound state
active. Due to their high affinity for GDP and very week intrinsic GTPase activity for
cycling between on (GTP bound) and off (GDP bound) positions, the activities of Gprotins are controlled mostly by other protein regulators. Guanine nucleotide exchange
factors (GEFs) activate GTPases by interacting with the inactive, GDP-bound state to
facilitate release of GDP (Fig. 3A) and allowing binding to GTP, which is more abundant
inside the cells than GDP (Lenzen et al., 1998). The exchange of GDP and GTP leads to
an allosteric change in the effector loop of GTPase (Boriack-Sjodin et al., 1998) which
allows active (GTP-bound) GTPase to be associated with a variety of different
downstream signaling molecules. As stated above, G-proteins generally have weak
intrinsic GTPase activity which allows them to stay active for long periods. Inhibition of
G-protein signaling requires GTPases activating protein (GAPs) which interact only with
GTP-bound GTPases and enhances hydrolysis of GTP to GDP.
The signaling activity of G-proteins is also regulated by their sub-cellular
localization, through post-translational modification. Post-translational modification of
G-proteins allows them to be anchored to the cell membrane. Caax (Cysteine-aliphaticaliphatic-any amino acid) motif is a target site for the addition of prenyl or farnesyl group
which mediates membrane targeting (Fig. 3B) (Gonzalez-Billault et al., 2012). In
addition, Ras proteins can be targeted to disordered domains or lipid rafts of plasma
membrane via a polybasic sequence or palmitolation site, respectively. For example, HRas and K-Ras 4A, which carry palmitoylable cysteine residues in their carboxy-termini,
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are transported to the lipid rafts in the plasma membrane. In contrast, K-Ras 4B which
has carboxy-terminal polybasic sequence is targeted to the more disordered regions of the
plasma membrane (Prior and Hancock, 2001). The regions in the plasma membrane with
cholesterol-rich micro domains called lipid rafts are important signaling platforms. In
these regions, receptors and downstream effector molecules of Ras signaling are
concentrated (Ehrhardt et al., 2002). Localization of Ras proteins and their regulators in
the specific regions of the plasma membrane is essential for their proper activation and
further intracellular signaling. For example, the localization of H-Ras in lipid rafts is
essential for activation of its downstream effectors Raf-1 and PI3K (Jaumot et al., 2002).
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A

B

Figure 3. Regulatory mechanisms of Ras GTPase proteins. (A) Small GTP binding
proteins are molecular switches that cycle between GTP bound (active) and GDP bound
(inactive) forms. They have high affinity to GDP which keeps G-proteins in an inactive
form. GEFs activate G-proteins by stimulating the release of GDP. G-proteins have low
intrinsic GTPase activity, which is activated by GTPase activating proteins (GAPs),
which result in inactivating G-protein signaling. (B) The C-terminal region of G-proteins
contains a hyper variable region (HVR) and adjacent to the HVR, a conserved CAAX
region, which is post-translationally modified by the addition of farnesyl (F-) or geranyl
geranyl (GG-) groups and subsequent methylation (CH3). (Adapted from Gonzalez
2012).
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1.6.3

GAPs and GEFs
Proper regulation of different Ras subfamily members is achieved by their precise

subcellular localization and their different affinities toward a variety of GEFs or GAPs.
Some studies show that there is specificity between individual members of Ras subfamily
and their particular GEFs and GAPs. In addition to their G-protein regulatory domains,
most GEFs and GAPs contain other types of domains that are responsible for proteinprotein interaction or protein lipid interactions, allowing them to participate in diverse
intracellular signaling pathways (Bos et al., 2007; Ehrhardt et al., 2002). For example,
GAPs and GEFS often include Src homology 2 or 3 (SH2 or SH3) domains for proteinprotein interaction, pleckestrin homology (PH) or protein kinase C conserved region 2
(C2) domain for protein-lipid and/or protein-protein interaction. In addition, GEFs and
GAPs exhibit distinct tissue specific expression patterns and subcellular localizations.
Therefore, the existence of a variety of GEFs and GAPs significantly contribute to
achieving precise regulation of G-proteins through multiple ways: 1) specificity for
particular members of Ras subfamily; 2) Ability to respond to the specific extracellular
stimuli through their interaction domains; and 3) their patterns of tissue specificity.
1.6.4

GEFs for Ras and Rap subgroups
During R7 photoreceptor differentiation of Drosophila, activation of Ras protein

occurs through product of gene son-of-sevenless. Sos1 and Sos2 are mammalian
homologs of this Ras regulator (Bowtell et al., 1992; Chardin et al., 1993). While Sos1
activates different targets such as H-Ras, N-Ras, K-Ras and M-Ras, Sos2 activates only
H-Ras (Liu et al., 1993; Ohba et al., 2000).
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RasGRP is a family of GEF protein that is regulated by Ca2+ or (DAG) through unique
calcium and DAG binding sites and has four members: 1) RasGRP1 (also known as
CalDAG-GEF II) that strongly activates H-Ras, N-Ras, K-Ras 4B, TC21/R-Ras2, and
weakley activates M-Ras (Ohba et al., 2000; Tognon et al., 1998); 2) RasGRP2 which
activates N-Ras, K-Ras 4B, Rap1, but not H-Ras (Clyde-Smith et al., 2000); 3) RasGRP3
(also known as CalDAG-GEF III) which activates H-Ras, R-Ras, Rap1A, and Rap2A, but
not RalA (Lorenzo et al., 2001; Yamashita et al., 2000); 4) CalDAG-GEF I is a splicing
variant form of RasGRP2 and strongly activates Rap1 and very weakly activates R-Ras
(Clyde-Smith et al., 2000; Ohba et al., 2000; Yamashita et al., 2000).
RasGRF1/2 contains an IQ motif that interacts with calmodulin, but there is no
any clear evidence about the function of IQ domain is available yet (de Hoog et al.,
2000). RasGRF1 activates H-Ras and M-Ras, but not N-Ras or K-Ras 4B, and RasGRF2
activates H-Ras, but not R-Ras (Gotoh et al., 2001; Jones and Jackson, 1998; Ohba et al.,
2000).
Epac is one of the RapGEFs which is activated by direct binding of cAMP (de
Rooij et al., 1998; Kawasaki et al., 1998). Both Epac1 and Epac2 have GEF activity only
toward RapGTPases (De Rooij et al., 2000; de Rooij et al., 1998; Kawasaki et al., 1998;
Ozaki et al., 2000). Two more GEFs for Rap GTPases are PDZ-GEF1 and C3G. Although
PDZ-GEF 1 by having PDZ (PSD-95, Dlg and ZO-1/2) domain and putative cAMPbinding domain selectively activates Rap GTPases, C3G has ability to weakly actives RRas (Gotoh et al., 1997).
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1.6.5

GAPs for Ras and Rap subgroups
The first characterized RasGAP is P120, (Gibbs et al., 1988; Trahey and

McCormick, 1987) which in addition to its Ras effector domain GAP Related Domain
(GRD) contains SH2, SH3, PH and C2 domains. Different studies have shown that C2
domain of RasGAPs is responsible for its translocation after an increase in the Ca2+
concentration(Filvaroff et al., 1992).
The GAP1 family includes four members of RasGAP proteins that contain C2 (Ca
dependent lipid binding domain) and PH domains (Mitin et al., 2005). These four
members contain GAP1IP4BP, GAP1m, CAPRI and RASAL. Although they have very
similar domain structure, regulatory mechanism for each member is different. The second
messenger Inositol 1,3,4,5, tetrakisphosphate (Ins(1,3,4,5)P4), which is produced by
Ca2+-regulated Ins(1,4,5)P3-kinase, affects GAP11P4BP RasGAP activity (Cullen et al.,
1995). Also, GAP1IP4BP exhibits PH-mediated constitutive association to the plasma
membrane possibly, through binding with PIP2 (Phosphatidylinositol 4,5-bisphosphate )
(Cozier et al., 2000; Lockyer et al., 1997). In contrast, GAP1m is localized in the cytosol
and after an increase in PIP3, translocates to the plasma membrane through an interaction
between its PH domain and PIP3 (Phosphatidylinositol (3,4,5)-trisphosphate) (Lockyer et
al., 1999). The members of this family, CAPRI and RASAL, translocate to the plasma
membrane after an increase in Ca2+ concentration through their C2 domain which results
in their RasGAP activity (Lockyer et al., 2001). Interestingly GAP1 family exhibits dual
specificity toward both Ras and Rap proteins with the exception of GAP1m which is a Ras
specific GAP (Kupzig et al., 2006).
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The tumor suppressor gene NF1 (Neuro fibromatosis type 1) encodes another
RasGAP. NF1 contains a Sec14 domain that functions as a Sec14-like lipid binding
domain (Dasgupta and Gutmann, 2003). SynGAP as a neuron specific RasGAP (Chen et
al., 1998; Kim et al., 1998), selectively associated with NR2B subunit of NMDA
receptors in postsynaptic membranes. This association between receptor and SynGAP
inhibits NMDAR-dependent ERK (extracellular signal regulated kinase) activation
(Myung et al., 2005). Also it has been shown that Ca2+/Calmodulin-dependent protein
kinase II (CaMKII)-mediated phosphorylation of SynGAP increases its RasGAP activity
by 70-95 % in vitro (Oh et al., 2004). Lastly, multiple isolated transcription variants of
DOC-2/DAB2 interactive protein (Dab2ip) have been shown to exhibit Ras GAP activity
in vitro (Chen et al., 2006; Homayouni et al., 2003a; Qiu et al., 2007a; Wang et al.,
2002b; Zhang et al., 2003b).
For Rap subgroup, Rap1GAP was the first to be identified (Polakis et al., 1991).
Spa1 as a prototype of the Spa family is another RapGAP and highly expresses in
lymphoid tissues (Kurachi et al., 1997). The Spa family is characterized by the presence
of a PDZ domain and consists of four members: Spa1, SPAL, SPAR, and E6TP1. SPAL
(Spa1-like protein) in hippocampal neurons bind to NMDA receptor-PSD 95 complex
(Roy et al., 2002, 1999). Similarly, SPAR (spine associated Rap GAP) forms a complex
with PSD-95 and the NMDA receptor in dendritic spines (Pak et al., 2001). E6TP1 as the
last member of this family interacts with E6, a viral oncoprotein (Gao et al., 1999).
Tuberin, as a tuberous sclerosis gene, TSC2, encodes another GAP for Rap proteins
(Wienecke et al., 1995). Finally, Dab2ip-L (GenBank accession number DQ473307), a
novel splicing variant form of Dab2ip, also exhibits RapGAP activity in vivo and in vitro

23

(See Chapter 3 Fig. 11B Fig. 12D). In this study I have shown that presence of PH
domain affect RapGAP activity and has critical role in the physiological function of
Dab2ip (See Chapter 3, Fig. 13).
1.7

Problem Statement
In summary, Dab2ip has been characterized in several mammalian species as a

novel member of GTPase-activating protein (GAP) for small GTPase Ras (Homayouni et
al., 2003a; Wang et al., 2002b; Zhang et al., 2003a). Dab2ip transcript appears to undergo
alternative splicing. In humans, at least three and in mouse two splice variants have been
reported to GeneBank database. The longest Dab2ip variant contains a full-length PH
domain compared to a partial PH domain in another isoform. Many GAPs contain PH
domains (Grewal, 2011), which can mediate both protein-protein and protein-lipid
interactions (Lemmon and Ferguson, 2000; Rizo and Sudhof, 1998).
Although several transcript variants of Dab2ip have been isolated and shown to
exhibit Ras GAP activity in vitro (Chen, 2006; Homayouni, 2003; Qiu, 2007), the
function of the novel Dab2ip isoform with the longer PH domain is still unclear. In order
to further understand the molecular, cellular and physiological functions of Dab2ip, the
following questions will be addressed in my study: 1) What is the gene structure of
Dab2ip?; 2) What is the role of CpG island methylation in Dab2ip gene in regulation of
its expression during brain development? 3) Does CpG methylation regulate alternative
splicing of Dab2ip mRNA? 4) Does the Dab2ip PH domain affect its Ras and Rap1
specificity? 5) Does Dab2ip PH domain mediate subcellular localization and/or
intramolecular interactions?
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Chapter 2: Analysis of Dab2ip DNA methylation and expression patterns of three
novel Dab2ip splice variants during brain development
2.1 Introduction
The human Dab2ip gene is located on chromosomal region 9q33.1-q33.3
spanning about 96 kb (Chen et al., 2002) and in mouse has been mapped at chromosome
2B (Chr2:35558266-35730994) and spans approximately 65 kb (Chen et al., 2006).
Dab2ip RNA appears to undergo alternative splicing (Chen et al., 2006; Homayouni et
al., 2003b; Qiu et al., 2007a; Wang et al., 2002a; Zhang et al., 2003b). Previously, a
TATA-less transcription start site (TSS) was identified on exon 1 of mouse Dab2ip gene
which resulted in three transcript variants with different exon1 at 5′ end, Ia, Ib and Ic
(Chen et al., 2006). Since this initial report, several more Dab2ip cDNAs have been
isolated from mouse and other species which differ in the number and the size of the
exons at both 5′ and 3′ ends. Differences at the 5′ end of Dab2ip transcript variants leads
to protein isoforms that have either a full-length, partial length or no PH domain at the Nterminus of the final protein. On the other hand, presence or absence of some exons at the
3′ end results in presence or absence of an SMH motif (Serine-Methionine-Histidine) at
the C-terminus of the final protein. For example, the human Dab2ip ortholog AIP1 (Acc#
AY032952) encodes a complete PH domain (Von Bergh et al., 2004).
Recently, our group isolated, characterized and reported a novel splice variant of
mouse Dab2ip, Dab2ip-L, (Acc# DQ473307). Dab2ip-L has a considerably longer PH
domain than those of previously reported. In the present study, we performed a thorough
analysis of Dab2ip genomic organization using a variety of bioinformatic resources. We
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found at least five transcription start sites (TSS) and multiple putative translation
initiation sites for mDab2ip. In addition, we identified four additional 5' exons for
mDab2ip than previously reported by others (Chen et al., 2006). We examined the
expression of three Dab2ip 5'-splice variants, originating from the first TSS in exon one.
It has been reported that the 5′ region of Dab2ip gene in human and mouse is CpG
rich which suggest that its transcription might be regulated epigenetically (Chen et al.,
2006, 2002). Also, Dab2ip has been suggested as a potential tumor suppressor. Wang et
al., first reported the growth inhibitory effect of the DIP1/2, a rat Dab2ip, on human
prostate cancer cell line (Wang et al., 2002b). Furthermore, several groups have shown
that the promoter region of human Dab2ip gene locus is more frequently methylated in
cancer cell lines and tumor tissues from prostate, breast, gasterointestine, liver and lung
compared to normal cell lines. It was suggested that these changes in methylation might
cause the down regulation of human Dab2ip gene expression and contribute to
tumorigenesis (Chen et al., 2003; Dote et al., 2004; Qiu et al., 2007a; Yano et al., 2005a).
In fact, Dab2ip expression has been found to be lower in several cancers, and associated
with epigenetic mechanisms such as DNA hypermethylation and histone deacethylation
(Chen et al., 2005, 2003). Interestingly, HDAC1 (histone acethyltransferase 1) inhibitors
and DNA methyltransferase inhibitors reversed the expression of Dab2ip to the normal
level in prostate cells (Chen et al., 2003; Qiu et al., 2007).
In addition, both mDab2ip and hDab2ip promoters have been shown to be
regulated by histone modification (Chen et al., 2006, 2003, 2002). Accumulating
evidence suggests that promoter methylation plays a critical role during differentiation
and maturation of the mammalian central nervous system (CNS) (Moore et al., 2012).
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However, methylation pattern of Dab2ip promoter during development has not been
examined thus far. In this study I found that mDab2ip contains three CpG islands located
within exons 2, 3 and 5. Previously only CpG on exon 5 was reported and studied by
Chen and colleagues and was shown to be the site of epigenetic control of mDab2ip
expression (Chen et al., 2006). Here, I show that methylation of exon 5 CpG (CpG85)
increases during cerebellar development and is positively correlated with the inclusion of
exon 5 in mDab2ip transcripts.
2.2 Material and methods
2.2.1

Bioinformatics
We deduced the exon-intron junction of mDab2ip by aligning its genomic DNA

sequence with hDab2ip cDNA clone (Acc# NP-115941). Transcription start site analysis
was performed by using Zenbu visualization tool and mouse Cap Analysis of Gene
Expression (CAGE) data available through FANTOM5 project website
(http://fantom.gsc.riken.jp/zenbu/gLyphs/#config=FP3UWqGsJVPtWNfSfupRk;loc=mm
9::chr2:35370843..35629647+) (Forrest et al., 2014; Severin et al., 2014). Dab2ip protein
motifs were examined using Conserved Domain Database (CCD) at NCBI
(http://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml) and MyHits protein motif search
tool (Pagni et al., 2007).
2.2.2 Animal handling and tissue collection
All animals used in this study were handled in accordance with a protocol
approved by Institutional Animal Care and Use Committee (IACUC protocol 0718) and
maintained at the university of Memphis animal care facility. Mice were kept on a 12/12
hr. light/dark cycle with food and water. All experiments were performed in agreement

27

with the institutional guide for animal care. Each female in the mating cages was
examined each morning for the presence of a vaginal plug. Once a plug was detected,
noon of that day was designated as embryonic day 0.5 (E0.5). Wild type mice with
genetic background KAHH were used for tissue collection and RNA isolation. Cerebella
were collected from postnatal mice at P8, P14, P21, and P30 after they were deeply
anesthetized with subdermal injection of Avertin (0.25 mg/g, body weight). Then,
cerebella were excised, snap frozen immediately and were stored in -80ºC for later
experiments.
2.2.3

Culture and maintenance of primary neurons
Brain was removed from KAHH background P2 mouse and in some cases cortex

was dissected out particularly. Then, to peel out meninges, the whole tissue was
transferred into 35 mm dish containing 1X HBSS (Hyclone). After removing meninges,
brain tissues were cut with very fine spring scissors with angled blades. For
homogenization, the whole tissue was transferred into 15 ml tube containing .25 %
trypsin (Hyclone) and incubated at 37 ˚C. After 30 minutes incubation, trypsin was
replaced with tritulation solution (DMEM/F12 [GIBCO] 10 ml+120 µl Dnase 120µl).
After 4 minutes centrifugation (1000rpm) in 4 ˚C, the pellet was resuspended with plating
medium (DMEM/F12 [GIBCO] 89%, 1%, Penycillin/streptomycin [Hyclone] 0.1%, Lglutamax .2% [GIBCO]). Then 2X105/well of cells were plated in 12 well dish (low
density). After 4 hours, the medium was replaced with culture media (DMEM/F12
[GIBCO] 97 %, B27 [GIBCO] ͂ 2%, L-glutamax [GIBCO] .24%). Two days later, AraC
[Sigma] was added to inhibit glial cell proliferation. Half of the media was changed every
3-4 days.
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2.2.4 Reverse transcription PCR
Based on the sequence information acquired from UCSC genome browser (mouse
genome assembly mm9, July 2007), PCR primers (table 2.1) were designed against
specific 5′ exons of mDab2ip and also between exon 1 and exon 19 and sometimes exon
20 to detect the expression of different Dab2ip transcript developmentally and detect
different exon expression separately. Total RNA was extracted from snap freezed mouse
cerebellum at different ages (P8, P14, P21, P30) using TRIzol reagent (Invitrogen).
cDNA was synthesized using Transcriptor First Strand cDNA Synthesis Kit (Roche) with
1 µg of total RNA and oligo-dT primers. One-tenth volume of the first-strand reaction
was used as a template for PCR amplification using the TaKaRa EX-Taq polymerase
(Clonetech Laboratories) and primer sets listed in the table 2.1 in different developing
age points as explained above. Thermal cycling program started with an initial
denaturation at 95 ºC for 5 min, followed by 35 cycles (94 ºC, 1 min; 61 ºC, 1 min; 72 ºC,
50 s) of amplification, followed by a 5 min extension at 72 ºC.
2.2.5 Quantitative Real-time PCR
Total RNA was isolated from mouse cerebellum at postnatal days 8, 14, 21 and 30
(P8, P14, P21 and P30) using TRIzol reagent (Invitrogen). Quantitative RT-PCR was
performed on a LightCycler 480 Real-Time PCR system (Roche) using primer sets
between exon 5 and 7 and exon 9 and 11 that encode full PH and GRD domain
respectively, (GRD domain forward primer: 5′-GCCTTCTGCAAGATCATCAAC-3′ and
reverse primer: 5′-GCTGATGAGCCGTTCACTG-3′) (PH domain forward primer: 5′CGCGGACAATGAGAGGTC-3′ and reverse primer: 5′GAGCAGGGACTCGTGTGAC-3′). Thermal cycling program started with an initial
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denaturation at 95ºC for 5 minutes, followed by 50 cycles of 95ºC for 10 s, 60ºC for 30s,
and 72ºC for 10 s, and final cooling at 40ºC for 10 seconds. The product sizes were
confirmed by agarose gel electrophoresis, and melting curves were analyzed to control
the specificity of PCR reactions. Dab2ip expression levels were normalized to β-actin.
The relative levels of Dab2ip expression were measured by a modified ΔΔCt (Pfaffl,
2001).
2.2.6 DNA purification and bisulphite modification
Genomic DNA was isolated from snap frozen mouse cerebella collected at
different time points (P8, P14, P21 and P30) using DNA purification kit (Qiagen)
according to the manufacturer’s instructions. Then, 500 ng of genomic DNA was
denatured and treated with bisulfite, which converts all unmethylated cytosines to uracils
without affecting methylated cytosine residues. All procedure was done by using EZ
DNA methylation-Gold kit (Zymo research) as described by manufacturer. The quality of
bisulfite treatment was checked by measuring OD at 260/280 nm. The methylation status
of each CpG island was analyzed separately by using bisulfite specific and methylation
specific PCR. Bisulfite specific (BSP) and methyl specific (MSP) primers listed in Table
2.1, were designed using Methyl Primer Express Software v1.0 (Applied Biosystems),
with some modifications (Table 2.1).
2.2.7 Methyl specific and bisulfite specific PCR
Methyl specific PCR was performed by using two sets of primers for each CpG
island. Each set of primers were able to distinguish between methylated (MSP/M) and
unmethylated (MSP/UM) DNA sequence. PCR was carried out with approximately 30 ng
of bisulfate treated genomic DNA in 30 µL total volume reaction containing 2.5 µl
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DMSO, 2.5 mM dNTP, and 0.20 U of TaKaRa EX-Taq DNA polymerase (Clontech
Laboratories). Thermal cycling program started with an initial denaturation at 95˚C for 5
min followed by 50 cycles of denaturation (95˚C for 30 seconds), annealing (65˚C for 45
sec, 60 ˚C for 45 sec and 55˚C for 45 seconds), extension (72˚C for 5 min), followed by a
final incubation at 72 ˚C for 15 min. PCR products were examined by agarose gel
electrophoresis. In another set of experiments, bisulfite specific PCR was performed as
described above using 20 ng of bisulfite treated genomic DNA and primers (BSP), listed
in Table 1. The PCR products were separated by agarose gel electrophoresis, purified
using Qiagen PCR purification kit, and directly sequenced using ABI model 3130XL
Genetic Analyser machine at University of Tennessee at Molecular Resource Center.
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Table 1. List of oligonucleotide primers and taqman probe sequences used in this study
Name

Sequence

Primers used for Dab2ip methylation
CpG 131/MSP/M/F
CpG 131/MSP//M/R
CpG 131/MSP /UM/F
CpG 131/MSP/UM/R
CpG 131/BSP/F
CpG 131/BSP/R
CpG 54/MSP/M/F
CpG 54/MSP/M/R
CpG 54/MSP/UM/F
CpG 54/MSP/UM/R
CpG 54/BSP/F
CpG 54/BSP/R
CpG 85/MSP/M/F
CpG 85/MSP/M/R
CpG 85/MSP/UM/F
CpG 85/MSP/UM/R
CpG 85/BSP/F
CpG 85/BSP/R

5'-CGTTTTTTTTCGGTTTTAAACGTTTTTA-3'
5'-CGCCCTACAAACATCGTTCCCCGCGCGCT-3'
5'-TGTTTTTTTTTGGTTTTAAATGTTTTTA-3'
5'-CACCCTACAAACATCATTCCCCACACACT-3'
5'-GAATTTGGGGAATATGGAGTAGAATAG-3'
5'-TTCCCTACCTTCTTTACTATAACCCAA-3'
5'-TTAGGTTAGGATTTTGTTCGTATTGATTTTTC-3'
5'-CTCCCGATACTCTTCCTAACGTTACCGCCGAC-3'
5'-TTAGGTTAGGATTTTGTTTGTATTGATTTTTT-3'
5'-CTCCCAATACTCTTCCTAACATTACCACCAAC-3'
5'-GTTTAGATATGGTTGTTGGGTATATGTT-3'
5'-AAAACCAAAACTACCCTACAAAATAACT-3'
5'-GAGTTTTTCGTTGTTCGATATAAAAGGTATTTTC-3'
5'-CGAATCTTAAATTATACCCATTAACCGAACGCCT-3'
5'-GAGTTTTTTGTTGTTTGATATAAAAGGTATTTTT-3'
5'-CAAATCTTAAATTATACCCATTAACCAAACACCT-3'
5'-GAGGTGGGTATTGTTTTTTGAGTAG-3'
5'-TACTCCTCCCCTCCAAATATTC-3'

Primers used for Dab2ip RT-PCR
E1-53.84-F
5'-CGCTCATGGAGACGGCCTCGGTTCATAAATCA-3'
E7-117.149-R
5'-AGCAGTAGTCCTGACCCAGGATGCTGCTGTGAA-3'
Dab2ip-EX1-1st ATG-F2 5′-AGGATCCGCCGCCAGATGGAATACAAAAGG-3′
Dab2ip-EX19-1192-R3
5′- CACGTCGACTGCAAAGCTCTTTGTCCTGCCCAGC-3′
Dab2ip-Ex20-507-R4
5′-CGGAGTCGACGAACACCAACAACTTCTCTGTAC-3′
Dab 2ip-Ex 7F
5′-CGCGATAAGTGGATGGAGAA-3′
Dab 2ip-Ex 10R
5′-GTCAGCGGATGAGCACTTG-3′
R.H lab-E2/7/P3/F
5′-TCCTGTCTGAGTCTTCACATCTTC-3′
R.H lab-E2/7/ID/F
5′-TGTGTGCAGATCCTGTCTGAGTCT-3′
R.H lab-E2/7/P3/R1
5′-CTTGATAATCACCTCCTCCTCCAT-3′
R.H lab-E2/7/ID/R1
5′-GCTGCTGTGAACGGGCTTGATAAT-3′
R.H lab-E3/7/P3/F
5′-CGGGAGGCCATCCTACTACT-3′
R.H lab-E3/7/ID/F1
5′-TACTTTGTAGGGCAGCCTTTGTCT-3′
R.H lab-E3/7/ID/F2
5′-ACTTTGTAGGGCAGCCTTGGTCTT-3′
R.H lab-E4/7/P3/F
5′-GCAGCATGTCAGAGAAAAACC-3′
R.H lab-E4/7/ID/F
5′-TTCCCGGCAGCATGTCAGAGAAA-3′
R.H lab-E5/7/P3/F1
5′-CCTCAAGGGCTCCATCAAG-3′
R.H lab-E5/7/P3/F2
5′-CCTCAAGGGCTCCATCAA-3′
R.H lab-E6/7/P3/F1
5′-AGAGAGGCCTACACTCCTATCGTT-3′
R.H lab-E6/7/P3/F2
5′-AAGATCCTGTGCTGGTCTGG-3′
R.H lab-E6/7/ID/F
5′-TGACAACCTTGGCAAGATCCTGTG-3′
R.H lab-E3/7/P3/R
5′-CTCGTGTGACCGAGACTCCT-3′
R.H lab-E3/7/ID/R1
5′-GCTGCTGTGAACGGGCTTGATAAT-3′
R.H lab-E3/7/ID/R2
5′-ATGCTGCTGTGAACGGGCTTGATA-3′
R.H lab-E4/7/ID/R1
5′-TGCTGCTGTGAACGGGCTTGATAA-3′
R.H lab-E4/7/ID/R2
5′-AACGGGCTTGATAATCACCTCCTC-3′
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Table 1. List of oligonucleotide primers and taqman probe sequences used in this study
Name

Sequence

Primers used for Dab2ip RT-PCR
R.H lab-E5/7/P3/R1
R.H lab-E5/7/P3/R2
R.H lab-E6/7/P3/R2
R.H lab-E6/7/ID/R

5′-CAGTAGTCCTGACCCAGGATG-3′
5′-GCTGTGAACGGGCTTGATAA-3′
5′-CTCGTGTGACCGAGACTCCT-3′
5′-GCTGCTGTGAACGGGCTTGATAAT-3′

Primers used for qRT-PCR
GRD domain-F
5'-GCCTTCTGCAAGATCATCAAC-3'
GRD domain-R
5'-GCTGATGAGCCGTTCACTG-3'
PH domain-F
5'-CGCGGACAATGAGAGGTC-3'
PH domain-R
5'-GAGCAGGGACTCGTGTGAC-3'
Primers used for cloning
FS, Ex7, HPH, F2
5′-CTGGAATTCGCCACCATGCCAAGGCT-3′
FS, Ex7, HPH, F3
5′-GTGCTGGAATTCGCCACCATGCCAAG-3′
FS, Ex8, noPH, F4
5′-CTGGAATTCGCCACCATGGAGAACCT-3′
FS, Ex8, noPH, F5
5′-GTGCTGGAATTCGCCACCATGGAGAA-3′
FS, Ex8, noPH, F6
5′-GTGCTGGAATTCGCCACCATGGAGAA-3′
FS, Ex19, R1
5′-GCTCGAGCGGCCGCCTAATGCATACT-3′
FS, Ex19, R2
5′-GCTCGAGCGGCCGCCTAATGCATACT-3′
Dab2ip-E1-EcoRI-F1
5'-GTGCTGGAATTCGCCATGGAGCCCGACTCCCTCCTGG-3
Dab2ip-BamHI-N1727-R1 5'-GTTGGATCCGGAAAGGGTCTCGGGGTTGG-3’
Dab2ip-BamH1-N2089-F1
5'-CGCAGCGGATCCTCAAGCTACTCAGAAGCCAATGAACCTGACCTGC-3′

MSP, methyl specific primer; BSP, bisulfite specific primer; F, forward; R, reverse

2.2.8

Statistical analysis
For qRT-PCR experiments, a two-tailed Student t-test (unequal variance) was

used to assess the significance of the change in three independent experiments.
Methylation sites within each CpG island were quantitated and a two-tailed Student's ttest (unequal variance) was used to assess the significance of the change in three
independent experiments.
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2.3 Results
2.3.1

Detecting genomic organization of Dab2ip
Previously, others reported that mDab2ip gene spans 65 kb and contains 14 exons

with one transcription start site (TSS) located on exon 1 (Chen et al., 2006). In this study,
we found that the mDab2ip gene spans 172,535 bp on chromosome 2 and includes 20
exons. By using primer walking strategy using primers listed in Table 2.2, I found
alternative expression of 7 exons at the 5′ end and the full length cDNA of Dab2ip on RTPCR gel (Fig. 4). Using CAGE data available through the FANTOM5 project, we
deduced five transcription start sites (TSS) located in exons 1, 2, 3, 5 and 6 (Fig. 5A, 5B).
In addition to one CpG island (CpG 85) on exon 5 that was reported by Chen et.al at
2006, we discovered two more CpG islands (CpG 131 and CpG 54) that are located on
exons 2 and 3, respectively (Fig. 5A, 5B). The presence of multiple CpG islands around
multiple TSSs suggests that mDab2ip gene may have alternative promoters, possibly
regulated by methylation of CpG islands, producing transcripts which encode different Nterminal protein domains.
Using UCSC genome browser, I was able to identify eight different putative
translation initiation codons with likely Kozak sequence in exons 1, 3, 4, 5, 6, 7, 8 and 9.
However, only five translation initiation sites (located in exon 3, 5, 7 and 9) were in
frame with the rest of the cDNA (Table 2.2). Two alternative termination sites were also
found on exon 19, followed by a large 3′ untranslated sequence. There are at least twelve
mouse Dab2ip cDNA clone available through UCSC Genome Browser. While the middle
region of all Dab2ip cDNA clones is identical, their 5′ and 3′ regions vary (Table 2.2).
The deduced protein sequence from the Dab2ip cDNA revealed several functional
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domains, including Plekestrin Homology domain (PH) domain, PKC conserved 2 (C2)
domain. GAP-related domain (GRD), NPXY motif and proline-rich region. Interesting,
alternative splicing in the 5′ region of Dab2ip results in proteins that contain either a fulllength PH domain, a partial PH-domain or no PH domain in the N-terminus. On the other
hand, alternative splicing at the 3′ region results in a slightly longer isoform containing an
additional 29 amino acids. Interestingly, the shorter Dab2ip protein isoform encodes an
SMH class I PDZ-interacting motif (Sheng and Sala, 2001).
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Figure 4. Detection of different exon expression using RT-PCR. Schematic of the
primer walking strategy used for detecting exons at the 5′ end of the Dab2ip cDNA. All
forward primers on exon 1, 2, 3, 4, 5, 6 matched with one reverse primer on exon 7. In
another set, primers were designed against exons 1 and 19 or exons 1 and 20 to detect the
size of the entire cDNA. (B) Gel electrophoresis RT-PCR from mouse cerebellum at
different ages at P30 shows DNA fragments with expected size (data have not been
shown for other ages). A set of forward and reverse primers on exon 7 and 10 was used
as a control. (C) The full length Dab2ip cDNA was around 7 kb using either primer sets
Ex1/Ex19 or Ex1/Ex20.
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Figure 5. Schematic of Dab2ip gene structure. (A) ZENBU genome browser view of
the FANTOM5 promoter level mammalian expression atlas data. The tracks shown here
include Entrez Gene mm9 gene boundaries, UCSC RefSeq mm9 gene boundaries, Phase
I CTSS data and predictions, and the Phase I CTSS pooled sequence tags from various
mouse tissues (bottom). (B) Schematic diagram of Dab2ip gene structure and the location
of primers and probes used for RT-PCR and real-time PCR experiments in this study.
The 5′-end of mDab2ip is associated with three CpG islands, five transcription start sites
and seven translation initiation sites.
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Table 2. Mus Musculus Dab2ip gene structure based on data from the UCSC
Genome Browser (NCBI37/mm9 assembly, July 2007). mDab2ip gene spans 172,535
bp on chromosome 2 and includes 20 exons. There are only five defined translation start
sites (located in exon 3, 5, 7 and 9) in the frame with the rest of Dab2ip cDNA. Also there
are two alternative termination start sites on exon 19. There CpG islands have been
detected on the exon 2, 3, and 5. This model suggests that exon 3 encodes nuclear
localization signal, PH domain is encoded by exon 5, 7 and 8 and finally exon 9 encodes
C2 and part of GRD domain. The rest of the GRD domain is encoded by exon 10 and 11.
It seems that SH3 domain is encoded by exon 15.
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2.3.2

Dab2ip TSS1 gives rise to three different transcript variants
Several groups have shown that both Dab2ip mRNA and Dab2ip protein is highly

expressed in the brain (Chen et al., 2006; Homayouni et al., 2003a). In addition, our
analysis of the FANTOM project data show that the expression of Dab2ip is highest in
the cerebellum (Fig. 5A). Notably, we detected two and sometimes three Dab2IP bands
on Western blots in lysates from cortex and cerebellum (Fig. 6). This observation
suggests the presence of different Dab2ip isoforms. Also Western blot data of mouse
cerebellum and cortex indicates that expression of these isoforms change
developmentally (Fig. 6). This result suggests that there may be alternative splicing in the
Dab2ip mRNA which leads to different isoform expression during development.
To detect possible mDab2ip 5′ splice variants, I performed RT-PCR using RNA
isolated from P30 cerebellum and specific forward and reverse primers targeting exons 1
and 7 (Table 2.1), respectively. Three bands (688bp, 554bp, and 385bp) were detected by
agarose gel electrophoresis, which were individually purified and sequenced (Fig. 7A).
DNA sequencing revealed that the largest band (688bp, variant 1a) included exons 1, 3, 4,
5 and 7. In contrast, the mid-sized band (554bp, variant 1b) included exons 1, 3, 4 and 7
and the smallest band (385bp, variant 1c) included exons 1, 4, 5 and 7 (Fig. 7B, 7C).
Using Conserved Domain Database (CCD) at NCBI
(http://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml) we found that exons 5, 7 and 8
encode a complete PH domain (112 aa). Thus, transcripts 1a and 1c, which contain exon
5 and 7, are able to code for an entire PH domain whereas transcript 1b lacks the Nterminal region of the PH domain (73 aa). Transcript 1a contains alternative translation
initiation sites located in exon 3 and 5. In contrast, transcripts 1b and 1c have only one
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translation initiation site located in exon 3 and 5, respectively. Interestingly, exon 3 codes
for an arginine-rich nuclear localization signal and detected by MyHits motif search tool.
Finally, none of the three variants isolated from the brain encoded exon 2 and 6 (Fig. 4B,
Fig. 7B, 7C). Expression of all three transcript variants a, b and c were found in the
cerebellum in different ages (P8, P14, P21, and P30) (data have not shown). Based on the
cDNA sequences in GeneBank, it seems that mDab2ip transcripts containing exon 6 are
possibly expressed in other tissues, such as spleen (Table 2).
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Figure 6. Western blot analysis of cerebellum and neocortex lysates from wild type
mice during development. (A) Note the expression of three Dab2ip isoforms in cortex
compared to the two isoforms expressed in the cerebellum. (B) Quantification of low
(110 KD) and high (150 KD) molecular weight Dab2ip isoforms in the murine
cerebellum using ImagJ. Note that the expression of the two bands are inversely regulated
during development.
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Figure 7. Evidence for alternatively spliced mDab2ip transcripts. (A) RT-PCR
amplification using primers on exon 1 (forward primer) and 7 (reverse primer) produced
three distinct bands (688pb, 554 bp, and 385 bp). (B) A table summarizing the presence
of specific exons in each of the three variants in A after DNA sequencing. (C) Schematic
diagram showing three different mDab2ip splice variants beginning with the first TSS on
exon 1.
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2.3.3

Methylation of mDab2ip gene increased during cerebellum development
The presence of CpG islands in mDab2ip gene suggests that its expression may be

regulated by DNA methylation. Previously, human Dab2ip promoter was shown to be
methylated in prostate, breast, gasterointestinal, lung and liver cancers (Chen et al., 2003;
Dote et al., 2004; Qiu et al., 2007b; Yano et al., 2005b). In this study, I examined
methylation of mDab2ip gene during cerebellar development at postnatal days P8, P14,
P21, and P30. CpG islands were examined by methyl-specific (MSP) PCR after bisulfite
treatment of genomic DNA using MSP primers (Table 2.1). I found that CpG131 was
predominantly unmethylated whereas CpG54 appeared to be both methylated and
unmethylated in all time points. In contrast, CpG85 appeared to be methylated at all timepoints (Fig. 8A). To further analyze the methylation status of mDab2ip gene, we
performed PCR amplification using bisulfite specific primers (BSP) listed in table 2.1,
followed by direct sequencing and quantitation of methylation sites. Consistent with MSP
result, we did not detect any methylation of CpG 131. CpG 54 was methylated
throughout cerebellar development. However its methylation did not change significantly
across developmental time points. On the other hand, the methylation of CpG85
increased significantly between P8 and P14 (P<0.05, t-test, n=3) as well as between P21
and P30 (P<0.01, t-test, n=3) (Fig. 8B, 8C).
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Figure 8. Analysis of mDab2ip methylation during cerebellar development at
postnatal days P8, P14, P21 and P30. (A) Methylation specific PCR of CpG131,
CpG54, and CpG85 using PCR primers which specifically amplified methylated (M) or
unmethylated (U) CpG islands. (B) Bisulfite sequencing of mDab2ip CpG131, CpG54,
and CpG85 from cerebella (n=3) collected at indicated postnatal days. (C) Quantitation
of CpG131, CpG54, and CpG85 methylation during cerebellar development by bisulfite
sequencing. Methylation is shown as an average percentage of total CpG's which were
found to be methylated in three separate animals at each time point. Statistical analysis
was performed using a two-tailed Student's t-test (unequal variance). *, p < 0.05, **, p <
0.01.
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2.3.4

Expression of different mDab2ip transcripts in the developing cerebellum
Since mDab2ip gene was differentially methylated during cerebellar development,

we next examined if Dab2ip transcripts also showed differential expression. Recent
evidence suggests that methylation of CpG sites located within exons may regulate their
inclusion during splicing (Luco et al., 2011). Therefore, we performed qRT-PCR analysis
using a probe which specifically targeted exon 5 (Taqman probe 41) and compared the
results to a probe that targets the core GRD region of Dab2ip (Taqman probe 51) (Fig. 5
B). Interestingly, we found that the ratio of exon 5 containing transcripts to the total
mDab2ip transcripts significantly (P< 0.05, t-test, n=3) increased between P21 and P30
(Fig. 9). The increase in exon 5 containing transcripts positively correlated (r = 0.76,
Pearson correlation) with CpG85 methylation. In contrast, there was no correlation
between exon 5 containing transcript and CpG54 methylation (r = 0.04, Pearson
correlation). These results suggest that methylation of CpG85 during cerebellar
development promotes inclusion of exon 5 in mDab2ip transcripts.
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Figure 9. Dab2ip mRNA expression during cerebellar development at postnatal days
P8, P14, P21 and P30. Quantitative RT-PCR was performed using a TaqMan probe
which recognizes either exon 5 or exons 11–12 (encoding the core GRD domain. Ct
values were normalized to β-actin levels at each time point. The graph shows the average
percentage of exon 5 containing transcripts (PH domain) to total mDab2ip transcripts
(GRD) in three separate mice. Statistical analysis was performed using a two-tailed
Student's t-test (unequal variance). *, p < 0.05, **, p < 0.01.
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2.4 Discussion
In this study, we performed a detailed analysis of the mouse Dab2ip gene,
identified multiple 5' Dab2ip transcript variants, and examined their expression levels
with respect to Dab2ip DNA methylation during cerebellar development.
We report here that mDab2ip gene spans over 172 kb, which is much longer than
the previously reported size by others (Chen et al., 2006) and that it contains three
different CpG islands, located on exons 2, 3 and 5. Previous studies have examined
methylation and histone acetylation of the region around exon 5 in Dab2ip (Chen et al.,
2006, 2003). Mapping experiments revealed a basal promoter region upstream of exon 5
in mDab2ip which drives its expression and is regulated by both DNA methylation and
histone acetylation (Chen et al., 2006). These results in combination with our observation
that multiple exons and transcription start sites exist in mDab2ip gene (Fig. 5A, 5B and
table 2.2) suggest that Dab2ip likely contains multiple promoters, resulting in expression
of multiple transcript variants. In addition, Chen and colleagues showed that histone
acetylation but not DNA methylation of the region around mDab2ip exon 5 correlated
with gene induction in mouse prostate adenocarcinoma cell lines. Our results (Fig. 8, Fig.
9) show that methylation of CpG85 in mDab2ip exon 5 is significantly increased between
P21 and P30 in the developing cerebellum and correlates positively with the inclusion of
exon 5 (encoding the N-terminal region of the PH domain). Our observations are
consistent with recent studies in other systems that implicate a critical role for exon
methylation in mRNA splicing and exon inclusion in the mature mRNA (Luco et al.,
2011; Maunakea et al., 2013).
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The presence of the additional 5' exons may have several important functional
implications. First, we found two additional translation initiation sites (with Kozak
consensus motif) on exons 3 and 5, which produce longer Dab2ip proteins. Exon 3
encodes a putative nuclear localization signal, which implies that Dab2ip may have a
nuclear function which has not been characterized to date. In addition, Dab2ip exon 5
encodes the N-terminal region of a PH-domain, which suggests that both Dab2ip protein
function and intracellular localization may be affected by the presence of exon 5 in this
transcript variant. Dab2ip is a member of RasGAP family (Wang et al., 2002b; Zhang et
al., 2003a). PH domains are commonly found in GAP proteins (Grewal et al., 2011;
Lemmon et al., 2002, Rizo and Sudhof, 1998) and mediate interactions with lipids, which
may allow GAP proteins to translocate to membranes in response to extracellular signals
(Lemmon and Ferguson, 2000; Rebecchi and Scarlata, 1998; Shaw, 1996). In addition to
lipid binding, the PH domains of some GEFs and GAPs also participate in intramolecular
interactions, which can be regulated by PtdIns (3,4,5)P3 (Drugan et al., 2000; Han et al.,
1998; Ma et al., 1998; Nimnual et al., 1998; Saito et al., 2001). Indeed, the PH domain of
AIP1/Dab2ip was shown to undergo intramolecular interaction (Zhang et al., 2003). The
presence of a full-length or partial PH domain in different Dab2ip transcripts may play an
important role in regulation of its molecular and cellular functions which in the next
chapter I have tested.
The cerebellum is an ideal brain structure to study the mechanisms of neuronal
development (Ha et al., 2015; Goldowitz and Hamre, 1998; Hatten et al., 1997). It has a
distinct layered structure which is primarily composed of Purkinje Cells (PCs) and
Granule Cells (GCs). PCs are born prenatally, but complete their migration and begin
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developing dendrites at P5-P8, during the time when GC are maximally proliferating
(Goldowitz and Hamre, 1998). The newly born GCs migrate passed PCs and inhabit the
inner layer of the cerebellum by P14. Finally, GCs extend axons (parallel fibers) that
form synaptic connections with PC dendrites in the outer layer of the cerebellum.
Importantly, maturation of the PC synaptic circuitry is completed between P21 and P30
(Miyazaki et al., 2003), during the time when we observed methylation of mDab2ip
CpG85 and a concomitant increase in PH-domain encoding exon 5 in mDab2ip
transcript. Interestingly, in our previous work, we showed that PC synaptic structures
were affected in mice with a targeted disruption of the first five exons in mDab2ip gene
(Qiao et al., 2013). Therefore, it is intriguing to speculate that methylation of mDab2ip
CpG85 may play a critical role in producing a Dab2ip variant with a full PH-domain
which may regulate synapse formation in the brain.
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Chapter 3: PH domain of Dab2ip is required for its Rap1GAP function
3.1 Introduction
Small GTPases function as molecular switches by cycling between an inactive
GDP-bound state (off position) and an active GTP-bound state (on position). Due to their
very weak intrinsic activity for this cycling, their activities are tightly regulated mostly by
two types of regulators: guanine nucleotide exchange factors (GEFs) and GTPase
activating proteins (GAPs). While GEFs facilitated the conversion from GDP to GTPbound state, GAPs accelerate the hydrolysis of bound GTP to GDP. The Ras subfamily is
a group of at least 13 small GTPases which are closely related, although each member
has unique functions and preferred upstream effectors and downstream targets (Ehrhardt
et al., 2002). The best known member of this family is Ras, although Rap1 has recently
attracted considerable attention (Bos, 2005; Bos et al., 2001; Kennedy et al., 2005; Stork,
2003). Rap1 and Ras are structurally similar, but Rap1 exhibits opposing actions to Ras
signaling such as K-Ras-mediated oncogenic transformation (Kitayama et al., 1989),
integrin activation (Hughes et al., 1997), and synaptic plasticity via receptor trafficking in
hippocampal neurons (Zhu et al., 2002).
Rap activity also is regulated by GEFs and GAPs whose expression can be tissuespecific. The first molecule that shown to has Rap1 GEF activity is C3G (Gotoh et al.,
1995). Other Rap1GEF proteins include CalDAG GEFI, Epac1/2, PDZ-GEF1, and one
isoform of phospholipase (PLC), PLCɛ (Bos et al., 2001; Ehrhardt et al., 2002; Stork,
2003). Since the first identification of Rap1GAP (Polakis et al., 1991) several RapGAP
proteins have been identified including Rap1GAPs I and II, Spa1 family members (SPA1, E6TP1, SPAL, and SPAR), Tuberin and most of the GAP1 family members
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(GAP1IP4BP, CAPRI, and RASAL) (Bos et al., 2001; Pak et al., 2001). Although the
GAP1m seems to be Ras specific, the other GAP1 family members are unique in that they
exhibit dual GAP activity for both Ras and Rap (Kupzig et al., 2006). Rap1 proteins are
involved in diverse cellular processes including cell proliferation, neurite outgrowth,
synaptic plasticity, integrin-mediated cell adhesion and formation of cadherin-mediated
adherent junctions in response to various extracellular signals and upstream effectors
(Bos, 2005; Hattori and Minato, 2003; Zhu et al., 2002). Therefore, spatio-temporal
activation of Rap1 is tightly regulated by many specific Rap GEFs and Rap GAPs
through their tissue specific expression, temporal regulation and subcellular localization.
However, scientists still have a poor understanding of mechanisms that regulate Rap
GAPs and Rap GEFs activity.
Dab2ip is believed to encode a novel Ras GAP (Chen et al., 2006; Homayouni et
al., 2003b; Qiu et al., 2007a; Wang et al., 2002a; Zhang et al., 2003b) and has been
implicated as a candidate tumor suppressor in various types of cancers (Qiu et al., 2007a;
Von Bergh et al., 2004; Wang et al., 2002a). As describe in Chapter 2, I have identified 3
different Dab2ip transcript variants that vary in their 5′ end (1a, 1b and 1c) (Salami et al.,
2015). Inclusion of different exons at the 5' end of Dab2ip mRNA affects the PH domain
in the final protein. Specifically, I identified three different Dab2ip transcripts with a
complete PH, partial PH or no PH domain. In this study, I provide the first evidence that
Dab2ip with full length PH and ½ PH domain can function as Rap1GAP in both HEK
293T cells and Cos7 cells. Interestingly none of Dab2ip isoform showed RasGAP activity
in the same cell lines. Thus, my results indicate that the Dab2ip PH domain mediates its
Rap1GAP specificity by some unknown mechanism. In preliminary FRET experiments, I
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found that the Rap1GAP activity of Dab2ip was localized to both plasma membrane and
cytosolic structures, indicating that the PH domain-induced Rap1 GAP activity may be
due to membrane targeting.
3.2 Material and methods
3.2.1 Antibodies and other materials
Rabbit anti-Dab2ip antibody which recognizes a 13 amino acid (aa 985-998)
region in Dab2ip C-terminus was described previously (Homayouni et al., 2003a). Other
antibodies were purchased commercially: anti-Myc (4A6; Upstate Biotechnology,
Temecula, CA, USA), Anti-HA (HA.11; Covance, Berkeley, CA, USA), anti-FLAG (M2;
Sigma, St. Louis, MO, USA), anti-C3G (Santa Cruz Biotechnology, Santa Cruz, CA,
USA), rabbit anti-Rap1 antibody (Upstate Biotechnology), mouse anti-Ras antibody
(Upstate Biotechnology), p44/42 MAP (Erk ½) and phospho-p44/42 MAPK (Erk ½)
antibody (Cell signaling technology). Raichu-HRas (Raichu-142X), Raichu-Rap1
(Raichu-409X) expression vectors were received from Dr. Michiyuki Matsuda/Jun-ichi
Miyazaki (Kyoto U., Japan). HA-hRasGAP, pSRα-FLAG-Spa1 and pRC-bac 5′-SOS-F
expression vectors have been received from Dr. Christian Widmann (Switzerland), Dr.
Masakazu Hattori (Kyoto U., Japan) and Lawrence Quilliam (Indiana university, IN),
respectively.
3.2.2 Molecular cloning of Dab2ip constructs
Previously, our group isolated a partial mouse Dab2ip cDNA that has high
sequence similarity to rat DOC-2/DAB2-interacting protein (DIP1/2) (Homayouni et al.,
2003). Using information in Celera Discovery Systems, we predicted a longer splice
variant of Dab2ip. This hypothesis directed us to successfully clone a novel transcript
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variant of Dab2ip (Dab2ip-L) from mouse brain (GenBank accession no. DQ473307)
(Fig. 1A) by using the EST and mouse genome sequence information. Sequence analysis
of the Dab2ip-L cDNA revealed that there is an open reading frame of 3399 bp which
encodes 1132 amino acid residues. As seen in Table 2.2, this cDNA does not include
exon3, which codes for a Nuclear Localization Signal (NLS). Accordingly, I found that
expression of this cDNA in mammalian cells did not show nuclear localization of Dab2ip,
however, it was expressed throughout the cytoplasm (Fig. 17).
Based on my results in the previous chapter, I designed primers to generate
Dab2ip expression vector expressing Dab2ip protein with partial different PH domains.
The pcDNA3-Dab2ip-Full PH (aa 1-1132) was used as a template for generation of the
following cDNA constructs: pcDNA3-1/2 PH (aa 97-1132) and pcDNA3-ΔPH (aa 1661132) (Fig. 10A). All PCR amplifications were done by using Pfu turbo DNA polymerase
(Agilent) and sequences were verified by DNA sequencing at The University of
Tennessee Molecular Resource Center (Memphis, TN). Western blot analysis of 293T
cells transfected with each of the three Dab2ip constructs shows expression of proteins at
the expected sizes (Fig. 10B). One more Dab2ip construct, FL Dab2ip Δ (575-698) aa,
was made to test the effect of downstream region of the GRD domain, (575-698) aa, on
the GPA activity of Dab2ip (Fig. 18A).
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Figure 10. Cloning and expression of different Dab2IP isoforms. (A) Schematic
diagram showing three Dab2ip constructs with different N-terminal regions
corresponding to the PH domain: pcDNA3- FLPH-Dab2ip, pcDNA3-Dab2ip-1/2PH (971132), and pcDNA3-Dab2ip-∆PH (166-1132). (B) Transfection of HEK 293T cells with
different Dab2ip constructs shows expression of the protein at the expected molecular
weights (between 100-150 KDa).
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3.2.3

Cell culture
Human embryonic kidney (HEK) 293T cells were obtained from ATCC

(Rockville, MD, USA) and were maintained in the Dulbecco’s minimal essential medium
(DMEM) (Hyclone) supplemented with 5% FBS and 100 U/ml penicillin plus 100 µg/ml
streptomycin at 37˚C, 5% CO2. In some other experiments Neuroblastoma 2a cells
(ATCC, Rockville, MD, USA) and Cos7 cells (ATCC, Rockville, MD, USA) were used
in the same medium, except for 10 % FBS. Transient transfection of cDNA constructs
were performed for all three cell lines by Lipofectamin 2000 (Invitrogen) and
Lipofectamin LTX (Invitrogen) transfection method.
3.2.4

Ras-GTP and Rap1-GTP assays
HEK 293T cells (1 X 106 cells/60-mmdish) or Cos7 cells (0.75 X 106 cells/60-

mmdish) were grown and transfected with cDNA by Lipofectamin method. The total
amount of plasmids was adjusted to 8 µg (in HEK 293T cells) or 5 µg (in Cos7 cells) in
each transfection using an empty control vector. In some cases, the cells were treated with
EGF (100 mM) two days after transfection for various durations. Next, the cells were
lysed with 600 µl of RBD lysis buffer (50 mM Tris-Cl [PH 7.4], 200 mM NaCl, 1% NP40, 2.5 mM MgCl2, 10% glycerol, 1 mM NaVO2, 25 mM NaF, 10 µg/ml aprotinin, and
10 µg/ml leupeptin). Five hundred µl of each lysate was incubated with either 30 µg of
RalGDS Ras-binding domain (RBD)-GST fusion protein immobilized with glutathione
sepharose or 10 µg of Raf-1 RBD agarose (Upstate) at 4ºC for 2 hrs with gentle agitation.
These complexes were washed 3 times and eluted by boiling for 5 min in 50 µl of 2X
SDS-PAGE sample buffer and separated by PAGE. Ras-GTP or Rap1-GTP in each
sample was analyzed by immunoblotting using rabbit polyclonal anti-Rap1 antibody
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(Upstate Biotechnology) or mouse monoclonal anti-Ras antibody (Upstate
Biotechnology).
3.2.5

Time-lapse imaging
Raichu-Hras and Raichu-Rap1 probes (received from Dr. Nakamura) are FRET

reporters designed to assay active Ras or Rap1 in live cells (Fig. 11A) (Mochizuki, 2001).
HEK 293T cells were plated on 35-mm glass-base dish (MatTek Corporation), which was
coated with 0.001% poly-L-lysine (Sigma). Lipofectamin 2000 (invitrogen) was used to
introduce Raichu probes cDNA into 293T cells, co-transfected with Dab2ip full-PH
construct alone or Dab2ip full-PH plus C3G-F constructs together. On the day of
imaging, the DMEM medium was exchanged to phenol red-free MEM (life
technologies), containing 5% fetal bovine serum. In some cases 10 ng/ml EGF was added
to the center of the dish directly and images were collected every minute for 20 minutes.
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Figure 11. Conformational changes of probes with Ras and Rap activity. (A)
Schematic representation of Raichu-Ras and Raichu-Rap bound to GDP or GTP and their
conformational changes in response to activaing and inactivating signals (figure was
adapted from Nakamura et al, 2005). (B) The distinct temporal dynamics of transient and
sustained activation of Ras and Rap (Sasagawa et al., 2005).
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3.2.6

Confocal microscopy
A confocal scanning fluorescence inverted Nikon (Melville, NY, USA) Eclipse

800 microscope with Ti-E A1rSi system was used for confocal microscopy with live
HEK 293T cells and fixed primary neuron cultures. Images were acquired with a 20X
(Plan apo, NA 0.75 WD 1mm), 40X (Plan apo, NA 1.0, WD .16mm) or 60X (Plan apo,
NA 1.4m, WD 0.21 mm) objectives. The microscope is equipped with four lasers. Two
lasers are at the proper range for excitation and emission wavelengths of Ras and Rap1
Raichu probes. I used DAPI laser to excite CFP (433 nm) and selected FITC laser to get
emission from YFP (530 nm) using the probes mentioned above. To adjust proper range
for emission wavelength, the virtual filter (VF) option from the spectral detector was
used. In the microscope settings, Ch1 (DAPI) provided CFP excitation (433-435 nm)
whereas Ch2 (FITC) provided emission (530 nm) wavelength for YFP. For CFP
excitation, I adjusted Ch1 excitation to 435nm and emission 455-480nm, which is out of
the emission range for YFP. The laser power was adjusted to the highest level and the
gain of this detector was adjusted to 0. For Ch 2, I adjusted the range of the emission
wavelength between 506 to 546 nm, minimized the laser power to 0, and maximized the
gain. In this experiment, the objective lens was focused on one cell and the images were
collected from 3 different channels, DAPI, FITC and FRET channels (adjusted virtual
filter), serially.
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3.3 Results
3.3.1 Dab2ip PH domain affects its Rap1 GAP activity in HEK 293T cells and Cos7
cells
Dab2ip is thought to be a Ras-specific GAP. It has been reported that GRD
domain of rat DIP1/2 exhibited efficient GAP activity to Ras, but not to Rap1 in vitro
GAP assays (Wang et al., 2002). However, recently our lab reported that Dab2ip
deficiency in mice results in higher activation of Rap1 in the cerebellum (Qiao et al.,
2015). Moreover, SynGAP which shows high sequence similarity to Dab2ip-L (SunHong Kim 2007, unpublished data) exhibits a higher level of Rap GAP activity than Ras
GAP activity in vitro (Krapivinsky et al., 2004). Thus, the goals of my study were to: 1)
Investigate if Dab2ip exhibits Rap1 GAP activity in cultured cells and 2) To explore the
role of the PH domain in Dab2ip Ras/Rap1 specificity in cultured cells.
I first examined the effect of transient transfection of different Dab2ip isoforms
on Ras GTPase activity in HEK 293T cells and Cos7 cells after treatment with EGF (10
ng/ml) for 5 minutes (Fig. 12A, 12C). Unlike previous observations, I did not find a
significant effect by different Dab2ip isoforms on Ras-GTP levels in these cells (Fig.
12B, 12D). Next, I investigated whether Dab2ip-L exhibited Rap1 GAP activity in
cultured cells. Activation of Rap1 was achieved by co-transfecting a C3G-F construct, a
membrane-anchoring CaaX motif-introduced C3G which efficiently stimulates activation
of endogenous Rap1 in HEK 293T cells (Tsukamoto et al., 1999). I found that C3G-F
effectively stimulated Rap1 in both 293T and Cos7 cells (Fig. 13). Importantly, cotransfection of 293T cells with Dab2ip suppressed the C3G-F induced activation of Rap1
(Rap1-GTP) (Fig. 13A, 13B). Similarly, co-transfection of Cos7 cells with Dab2ip
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inhibited C3G-F induced Rap1 activation (Fig. 13C, 13D). The GAP activity of Dab2ip
was comparable to Spa1, which is a well-characterized Rap1 specific GAP (Tsukamoto
1999).
Next, I investigated whether the Dab2ip PH domain plays a role in its Rap1GAP
activity, since some PH domains have been implicated in the translocation of host
proteins to plasma membrane and also may function as regulatory domains in response to
various extracellular signals (Lemmon et al., 2002). Interestingly, I found that Dab2ipΔPH failed to inhibit the C3G-F stimulated Rap1 activation (Fig. 13), whereas both the
full length PH and ½ PH containing Dab2ip exhibited Rap1 GAP activity. These results
indicate that full PH and ½ PH domains are essential for Rap1 GAP activity of Dab2ip.
To confirm these results, I also tested the Dab2IP constructs in Neuro2a cells. However, I
did not detect Rap1GAP activity for any of the Dab2ip constructs in Neuro2a cells (data
not shown). This result indicates that the Rap1 GAP activity is dependent on the cell type,
which suggests that other signaling molecules are necessary for Dab2ip Rap1 GAP
activity.
Finally, according to some preliminary data from our lab, we have suggested a
model for Dab2ip full length. This model supports intramolecular interaction of Dab2ip
trough PH domain and downstream region of the GRD domain. To test if this
intramolecular interaction affects RapGAP activity of Dab2ip, I have deleted
intramolecular region corresponding to the amino acids 575 to 698 (Fig. 18A). RapGAP
experiment using this construct showed this new clone is unable to inactivate Rap1 in
HEK 293T cells after co-transfection with C3G-F (Fig. 18B). This data indicates that
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Figure 12. Dab2ip-L does not exhibit RasGAP activity in cultured cells. Dab2ip Ras
GAP activity was examined inHEK 293T cells (A, B) and Cos7 cells (C, D) which were
transfected with either control or different Dab2ip cDNA clones. Two days after
transfection, cells were treated with 10 ng/ml EGF for 0 and 5 min. The cells were lysed
and incubated with Raf-1 RBD agarose beads and the resulting complexes were separated
by SDS-PAGE. The presence of Ras-GTP was determined by immunoblot analysis using
anti-Ras antibody. To verify the effectiveness of EGF treatments, phosphorylation of
ERK was monitored in whole lysates using anti-pERK antibody. The levels of Ras, ERK
and Dab2ip proteins were examined in lysates using anti-Ras, anti-ERK and anti-Dab2ip
antibodies, respectively. Statistical significance was determined using a two tailed
Student’s t-test with unequal variance. *, p < 0.05; **, p<0.01; ***, p<0.001.
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Figure 13. Dab2ip-L exhibits Rap1GAP activity in cultured cells. HEK 293 T cells
(A, B) and Cos 7 cells (C, D) were transfected with C3G-F cDNA along with either
Dab2ip cDNA clones, RasGAP-HA (as negative control), or Spa1-flag (as positive
control). After transfection, cells were lysed and incubated with GST-RalGDS-RBD
fusion proteins immobilized with glutathione-Sepharose. The resulting complexes were
separated by SDS-PAGE, and the presence of Rap1-GTP was determined by immunoblot
analysis using anti-Rap1 antibody. To verify the expression levels of various transfected
proteins, lysates were analyzed by immunoblotting using antibodies for Dab2ip, HA,
Flag, and C3G. Statistical significance was determined using a two tailed Student’s t-test
with unequal variance. *, p < 0.05; **, p<0.01; ***, p<0.001.
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downstream region of GRD domain is necessary for Rap1GAP activity of full length
Dab2ip in this cell line.
3.3.2 Effect of Dab2ip on Rap1 GTPase activity in live cells
In the previous section, I used biochemical pull-down experiments to test the
effect of Dab2ip on Ras and Rap1 activities in cultured cells using constructs which have
different regions of the PH domain. An important question remains whether the PH
domain is responsible for targeting Dab2ip to the correct subcellular compartments,
which then affects Dab2ip’s specificity toward Rap1. To address this question, I
developed a live cell imaging approach using fluorescence resonance energy transfer
(FRET) probes that were previously described (Raichu-Hras and Raichu-Rap1) (Fig.
10A).
To test whether the FRET technique worked properly, I tested Ras activation after
treatment of Raichu-Hras transfected 293T cells. In this experiment, Raichu-Hras was
excited with DAPI laser before and after EGF treatment for various durations. The GFP
signal shows activated Ras, whereas the DAPI signal shows inactive Ras (Fig. 14, Fig.
19). To show the time course and distribution of active Ras, I collected the images of one
live cell every min following EGF treatment for 20 minutes. At minute 0, active Ras was
distributed locally at focal adhesion sites. Notably, the basal activation of Ras was quite
high. One minute after adding EGF to the medium, I observed a re-distribution of
activated Ras to the plasma membrane, presumably where activated EGF receptors
reside. Five minutes after EGF treatment, which is typically the peak of EGF receptor
activity, activated Ras was highly localized at the plasma membrane (Fig. 14, Fig. 19).
After 5 min EGT treatment, the active Ras decreases at the plasma membrane and
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redistributes to the focal adhesion sites. High signal and no difference in the signal
intensity before and after EGF treatment indicates that the basic level of the Ras activity
is very high in HEK 293 T cells and only receptor distribution pattern changes during this
time course experiment. Since in biochemical experiments, I did not detect RasGAP
activity by Dab2ip, I did not test various Dab2ip constructs in 293T cells using FRET.
Using Raichu-Rap1, I examined the subcellular distribution of Rap1-GAP activity
of different Dab2ip constructs in live 293T cells (Fig. 15a). In this experiment, activation
of Rap1 was achieved by co-transfection of the cells with C3G-F (Fig. 15e, 15f). FRET
analysis showed that full-PH Dab2ip opposes GEF activity of C3G-F for Rap1 in 293T
cells. This observation confirms our previous biochemical data that indicates Rap1GAP
activity of Full PH-Dab2ip isoform in HEK 293T and Cos7 cells (Fig. 13). To determine
the subcellular localization of Dab2ip Rap1 GAP activity, FRET ratios were measured at
the cell membrane and cytoplasm of cells. I found that FLPH-Dab2ip inactivates Rap1 in
both the cytoplasm and cell membrane (Fig. 15B). This result suggests that the
mechanism of Dab2IP Rap1 specificity does not involve the lipid binding properties of
PH domain and translocation to the plasma membrane.
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Figure 14. Live monitoring of activated Ras in 293T cells using FRET. Time laps
activation of Ras distribution after EGF stimulation in HEK 293T cells. The distribution
of activate Ras (green) changes with the duration of EGF stimulation. At 0 min EGF
treatment, the strong green signal relative to the weak blue signal (in active Ras), at focal
adhesion sites indicate a high basal levels of activated Ras in 293T cells.
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Figure 15. Live monitoring of activated Rap1 using FRET. (A) Inactive (blue) and
active (green) Rap1 was examined in 293T cells transfected with either Raichu-Rap alone
(top panel), or along with C3G (middle panel) or C3G plus Dab2ip (bottom panel). In
basal conditions, we observed roughly equal amount of active to inactive Rap1 in 293T
cells. However, C3G co-transfection showed high levels of active Rap1 in the plasma
membrane and cytosolic structures. Co-transfection with Dab2ip inhibited the C3G
activation in these regions. (B) Quantification of FRET shows that the ratio of active to
inactive Rap decreases with Dab2ip co-transfection at both the plasma membrane and
cytosolic regions.
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3.4

Discussion
In this study, I demonstrated that Dab2ip containing a full-length PH domain

functions as a Rap1 GAP in two different cell lines. The Rap GAP activity was localized
to both the plasma membrane and cytosolic regions of the cell. Also in this study, I
provided the first evidence that shows the N-terminal region of the PH domain in Dab2ip
is important for its RapGAP activity. Since its discovery, Dab2ip has been considered to
be a Ras-specific GAP (Wang et al., 2002). However, the fact that SynGAP, which is
highly similar in amino acid sequence to Dab2ip-L showed more GAP activity for Rap1
than Ras in vitro (Krapivinsky et al., 2004) and also SynGAP, and the presence of a
similar PH domain in SynGAP (McMahon et al., 2012), prompted us to test the
possibility that some Dab2ip isoforms may have Rap1 GAP activity. In the present study,
although I clearly showed that, in HEK 293T cells and Cos7 cells, the presence of PH
domain is necessary for RapGAP activity of Dab2ip (Fig. 13), I was not able to detect
any Rap1GAP activity of Dab2ip in Neuro 2a cells (data did not shown). Thus, at present
it is unclear if the RapGAP function of Dab2ip through PH domain is cell-type specific or
due to other technical factors.
I was not able to detect significant Ras GAP activity with different Dab2ip
isoforms after EGF treatment in 293T and Cos7 cells (Fig. 12). This may be due partially
to high levels of basal Ras activity in these cells lines. In addition, this may be due to low
transfection efficiency which results in expression of Dab2ip in a subset of cells which
received EGF stimulation. Therefore, at present it is unclear whether Dab2ip can function
as a true dual-specificity GAP for both Ras and Rap, which has been suggested for other
GAPs such as GAP1 family members and SynGap (Kupzig et al., 2006).
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FLPH-Dab2ip isoform is a highly organized protein with structural domains that
are likely to be involved in the regulation of its localization and GAP activity (Fig. 1B).
PH and C2 domains both have potential to bind to phospholipids (Lemmon and Ferguson,
2000; Rizo and Sudhof, 1998). The presence of C2 and PH domains both strongly
suggests that FLPH-Dab2ip may respond to phospholipid signaling. In addition, there is
evidence that PH domains of GEF and GAP proteins are involved in intramolecular
interactions that inhibits the catalytic function of the host protein (Drugan et al., 2000;
Ma et al., 1998; Nimnual et al., 1998). Others have shown that phospholipid binding of
PH domain, particularly interaction between PtdIns(3,4,5)P3 and PH domain, relieves
the auto inhibition of the host protein (Drugan et al., 2000; Han et al., 1998; Saito et al.,
2001). Our lab previously showed that PH domain of Dab2ip is able to interact with PIP3
as well as to an internal region downstream of the GRD domain (Sun-Hong Kim,
Dissertation, 2008). In my studies, I showed that FLPH Dab2ip can inhibit Rap1
activation at both the plasma membrane and cytosolic structures. The precise mechanism
by which the PH domain regulates Rap1 GAP activity of FLPH-Dab2ip needs further
investigation. In addition to mediating membrane binding, the Dab2ip PH domain may
regulated specificity to Rap1 via its intramolecular interaction near the GRD domain.
The domain structure of SynGAP and Dab2ip are highly similar and both protein
have been reported to have Ras GAP activity (Kim et al., 1998; Wang et al., 2002a;
Zhang et al., 2003). There is evidence that indicates SynGAP negatively regulates Ras
activity at excitatory synapse (Kim et al., 1998), is important in synaptic plasticity (Pena
et al., 2008) and functions in neuronal development (Kim et al., 2003). Interestingly,
SynGAP shows dual specificity for Rap and Ras (Pena et al., 2008). Similar to Dab2ip,
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the most differences among three SynGAP isoforms is at the N-terminus through the
presence of the PH domain and its size (McMahon et al., 2012). SynGAPs A and B
contain unique peptide sequences and a complete pleckstrin homology (PH) domain that
may regulate lipid binding and protein–protein interactions. SynGAP C is shorter, does
not have the unique peptide sequence and lacks a complete PH domain (McMahon et al.,
2012). Structural identity between SynGAP and different Dab2ip isoforms in the amino
acids sequence of their catalytic domain (GRD) as well as the size of the PH domain
suggest the similar functions for Dab2ip and SynGAP's in the brain.
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Chapter 4. Summary and Conclusions
Dab2ip (DOC-2/DAB2 interacting protein) is a novel member of the Ras GTPaseactivating protein (RasGAP) family which was previously identified by virtue of its
interaction with Disabled-1 and 2 family proteins. Several Dab2ip transcript variants have
been identified to date. Previously our lab identified a longer Dab2ip transcript, termed
Dab2ip-L (Genbank accession number, DQ473307), from mouse brain. Dab2ip-L cDNA
encodes 1132 amino acids containing a Pleckstrin homology (PH) domain, PKC
conserved 2 (C2) domain, GAP related domain (GRD), NPxY motif, and prolin-rich
region. Dab2ip-L protein contains a longer PH domain than previously reported shorter
Dab2ip transcript variant and is predominantly expressed in the brain.
In chapter 2, using bioinformatic resources, we found that the mouse Dab2ip gene
has five additional transcription start sites, five translation start sites and two more CpG
islands than previously reported. In this study, I characterized three transcript variants
from the first transcription start site (TSS) on exon1, which differ in the presence or
absence of exons 3 and 5. I showed that methylation of CpG 85, which is located on exon
5, correlated with the inclusion of exon 5 in the mRNA during cerebellar development.
Our data shows that exon 5 codes for the upstream region of a PH domain.
In chapter 3, I demonstrated that FLPH Dab2ip isoform exhibits GAP activity
toward Rap1 and not Ras, as previously reported. Using FRET, I showed that the fulllength PH domain containing Dab2ip inhibits Rap1 activation at both the plasma
membrane and cytosolic structures, indicating that the PH domain may be important for
targeting Dab2ip to Rap1 containing structures.
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During the past few years, it has been increasingly evident that Ras and Rap1
activities are tightly balanced in response to incoming synaptic activity and/or external
stimuli in order to regulate various neuronal functions such as maintenance of proper
synaptic strength, spine morphogenesis, and dendritic development (Chen and Ghosh,
2005; Kennedy et al., 2005; Tada and Sheng, 2006). Ras is essential for cell proliferation
(Xie et al., 2006) and Rap plays an important role in determination of neuronal polarity
(Schwamborn and Püschel, 2004), spine morphology (Pak et al., 2001) and dendritic
outgrowth in developing neurons (Fu et al., 2007).
In mice, the process of neuronal migration and differentiation is finished in the
cerebellum by P20 (Teigler et al., 2009). Rap1 GTPase is important for cytoskeletal
changes during neuronal migration and early differentiation. Differentiation of neurons
involves formation of dendrites and axons (cell polarity) followed by dendritic
arborization. The final stage of differentiation requires that neurons stop branching and
establish synapses. In the cerebellum, dendritogenesis and axogenesis must stop by P21,
so that synapse formation can begin primarily between granule cell parallel fibers and
Purkinje cells.
My results are significant because I have demonstrated that during cerebellar
development, epigenetic control of exon 5 inclusion in Dab2ip mRNA causes expression
of the full PH domain in Dab2ip at around P21, the period when synaptogenesis must
begin. Therefore, I propose that the full PH domain Dab2ip is necessary to turn off Rap1
signaling during this critical developmental time point, to allow completion of
differentiation (Fig. 16). Reelin plays an important role in synaptogenesis. We postulate
that Rap1 is transiently turned off by the expression of full PH domain containing
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Dab2ip, through methylation-mediated inclusion of the exon 5. FLPH Dab2ip inactivates
Rap1 in the cell and cytosolic membranes, particularly near the Reelin receptors through
its interaction with Dab1, the downstream cytosolic adapter protein that mediates Reelin
signaling. Indeed, our lab has shown that mice which lack Dab2ip exhibited lower
parallel fiber synapses, as measured by VGlut1 staining (Qiao et al., 2013). In addition,
our preliminary data shows that Rap1 is active only in very early stages of the cerebellum
development (unpublished data). Together, these results suggest that increasing
expression of Dab2ip with full PH specifically inactivates Rap1 at a specific time during
cerebellum development to allow completion of synapse formation. Our data also suggest
that Dab2ip may mediate certain aspects of Reelin signaling during brain development.
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Figure 16. Working model which shows the correlation between methylation of
Dab2ip gene and inactivation of Rap1 during cerebellar development. (A) At P8,
absence of Dab2ip gene methylation leads to expression of the short Dab2ip isoform
without full PH domain which is not able to inactivate Rap1. Active Rap1 is important
for cytoskeletal changes involved in dendrite arborization of the Purkinje cells early
during cerebellar development. (B) At P21, secretion of Reelin plays an important role in
synaptogenesis. We postulate that Rap1 is transiently turned off by the expression of full
PH domain containing Dab2ip, through methylation-mediated inclusion of the exon 5.
FLPH Dab2ip inactivates Rap1 in the cell and cytosolic membranes, particularly near the
Reelin receptors through its interaction with Dab1, the downstream cytosolic adapter
protein that mediates Reelin signaling.
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Supplementary

Supplementary method 1
Immunocytochemistry
Cells were fixed by adding 500µl of 4% formaldehyde fixative solution directly
into the culture medium. After 2 minutes the pre-fixation culture medium was replaced
with 300-400 µl of 2% formaldehyde fixative solution and incubated with 2%
formaldehyde for 20 minutes at room temperature. Wells that contain coverslips were
washed with PBS twice, then covered with 400µl of wash buffer. After wash, coverslips
blocked with blocking buffer (10% normal donkey serum, 0.1% triton X-100 in PBS DD
H2O) and incubated for 45 minutes at room temperature. Primary antibody was diluted in
dilution buffer (PBS 1X, 1% bovine serum albumin, BSA, 1% normal serum, 0.1% triton
X-100. 0.01% sodium azide) and used to incubate coverslips in room temperature for 1
hour or alternatively overnight at 2-8 ˚C. After proper time incubation in primary
antibody, coverslips were rinsed twice with wash buffer. Next incubation is for 1 hour
diluted secondary antibody in the dark. From this step no light exposure is necessary.
After rinsing with wash buffer, proper amount of DAPI solution was added to each well
and incubated in room temperature for 2-3 minutes. The final wash with PBS and water is
necessary. Then coverslips were removed from well and mounted toward microscope
slide.
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a) 25 µm

b) 25 µm

c) 10µm

Figure 17. Subcellular localization of FLPH-Dab2ip in primary neuron culture.
To determine the expression pattern of Dab2ip, Dab2ip cDNA containing the full-length
PH domain (FLPH-Dab2ip) which was tagged with myc was expressed in cortical
primary neuron culture. Using anti-myc antibody, I found that this isoform diffusely
localized throughout the neurons, including cytoplasm, cell membrane and neuritis. I did
not detect any expression of Dab2ip in the nucleus. Considering the sequence of this
construct, this observation suggests exon 3, containing a putative NLS (nuclear
localization signal) is missing from the transfecting isoform (Table 2.2). This result was
consistent with the previous observation which showed Dab2ip is specifically expressed
in the cell bodies and dendrites of the neurons in the mouse cerebellum (Qiao, 2015).
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B

Figure 18. Interaction between PH and internal region of Dab2ip regulates its
RapGAP activity. (A) Schematic diagram showing Dab2ip construct with lack of
downstream region of the GRD domain which corresponds to amino acids 575-698. (B)
The graph shows the significance difference between RapGAP activity of full length
Dab2ip compare to Dab2ip isoform which lacks downstream region of the GRD domain
(***, p<0.001) which indicates that for RapGAP activity of Dab2ip both PH domain and
downstream region of the GRD domain are necessary.
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Figure 19. Live monitoring of activated Ras in 293T cells using FRET. Time laps
activation of Ras and receptor distribution after EGF stimulation in HEK 293T cells. The
distribution of activate Ras (green) changes with the duration of EGF stimulation. At 0
min EGF treatment, the strong green signal relative to the weak blue signal (in active
Ras), at focal adhesion sites indicate a high basal levels of activated Ras in 293T cells
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